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1. INTRODUCTION 
The first thing we do for ourselves after birth is to breathe. This connects us to 
the outside world. Life process carried out by living beings through involving the 
capture of oxygen from the environment and the expulsion of carbon dioxide 
produced in the cells. This vital process is known as breathing. It also plays an 
important role in the regulation of blood pH, a process known as acid-base balance 
and maintenance of metabolic process of cellular respiration. 
When this vital breathing tract (respiratory tract) is particularly exposed to 
pollutants, cigarette smoke as well as ozone and other free radicals affects the natural 
mechanism of filtering and clearing of such pollutants through respiratory epithelium, 
trachea bronchial lymphatic and alveolar macrophages result in the progression of 
respiratory disease known as bronchial asthma. The results of recent epidemiological 
studies show that pollution peaks often coincide with an increase in the frequency of 
asthma attacks. 
Asthma is a disease of airways that is characterised by increased 
responsiveness of the trachea bronchial tree to a variety of stimuli resulting in 
widespread spasmodic narrowing of the air passages which may be relieved 
spontaneously or by therapy. Asthma is an episodic disease manifested clinically by 
paroxysms of dyspnoea, cough and wheezing. However, a severe and remitting form 
of the disease termed status asthmatics may prove fatal. 
[1] 
Between 100-150 million people suffering from asthma worldwide, which 
deaths from this condition have reached over 1,80,000 annually. India has on 
estimated 15-20 million asthmatics. 
[2]
  
The human economic burden associated with asthma are estimated to exceed 
those of TB and HIV /AIDS combined. It is also the only chronic disease with 
morbidity and mortality has increased over the last twenty five years. 
The health effects of patients with severe asthma are very stressful. This is 
especially true for young asthmatics who are often severely limited in their quality of 
life. Currently, the main types of drugs used to treat asthma are bronchodilators and 
anti-inflammatory agents, which relieve symptoms of bronchospasm and reduce 
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inflammation of the airways. However, therapy with these drugs is not completely 
effective and result in adverse effects. 
However, a proportion of patients with severe asthma variants required 
additional drugs to get the disease under control. Often required long-term moderate 
to high doses of oral glucocorticoids. Steroids are even inhaled in treatment which 
exhibit lot of side effects even at low doses like infection due to yeast in the mouth, 
hoarseness of voice, bone loss and glaucoma etc., which makes the condition of the 
patient even worse. 
[3]
 
Hence, lack of safe drugs and limited access to minimum income people used 
treatments stimulate the search for new substances potentially useful in the treatment 
of asthma. Therefore, there is no doubt promising therapies are necessary and 
important. Nowadays researchers have been trying for years to develop new 
therapeutics and therapeutic methods from natural sources especially Siddha system 
of medicines to treat asthma successfully.  
Natural products of herbal origin, represent great pharmacological potential 
for asthma, because they can provide various molecules with specific mechanisms for 
the treatment and control of disease. The search for more effective and specific to the 
process for asthma shows that the demand for Siddha herbal products is promising 
and has an important role in the discovery of new effective and less toxic therapies for 
asthma.  
The discovery of the connection between plants and health is responsible for 
the beginning of a new generation of treatments, including drugs derived from plants, 
the use of the plant itself or its parts, supplementary diets and functional foods. 
Several drugs with asthma action were isolated from medicinal plants for respiratory 
problems, such as atropine, theophylline and chromoglycates. Therefore, the Siddha 
system of medicine is still a valuable source of new anti-asthma therapeutics.  
Today, nature has distinguished itself as a source of new active agents for a 
wide variety of diseases. In the past 25 years, including new drugs approved, 
approximately 30% are natural products or their derivatives. 
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Natural products, including plants, animals and minerals have been the basis 
of treatment of human diseases. History of medicine dates back practically to the 
existence of human civilization. Historically, the majority of new drugs have been 
generated from natural products (secondary metabolites) and from compounds 
derived from natural products. 
[4], [5] 
According to Siddha, the five winds abiding in particular locations keep the 
living being going. They are Prana, Udana, Samana, Viyana, Abana .The wind 
moving in the mouth or face is called “Prana”  “breathing forward”. It upholds the 
body. It cause the food to enter and supports the other forces of the like- breath of the 
body. When upset it causes respiratory disorders include asthma and similar 
afflictions. 
[6] 
 In Siddha system, bronchial asthma can be compared with Eraippu irumal and 
also termed as Swasa kasam. It also portrays that the humour “kabam” is the cause for 
“Swasa kasam”.  
“கபத்தினையன்றிக் காசசுவாசங் காணாது” 
     _  பிணிகளின் முதற் காரணம்[7] 
There are so many herbal, herbo-mineral formulations are available in Siddha 
system of medicine to treat asthma effectively. One of the poly herbo mineral 
preparation ‘Kadukkai Vadagam’ has been recognized as an effective treatment 
asthma mentioned in Siddha classical literature “Athmaratchamirtha Vaidhiya Saara 
Sangiragam (part -2)”. It is used with increasing frequency in recent years. But this 
drug formulation is not yet validated scientifically.  
Hence, an attempt was made to find out the good possibilities of therapy and 
hope for further good clinical research in this area, Kadukkai Vadagam was selected 
for my dissertation topic to validate its therapeutic potential and safety profile through 
various physic-chemical, biochemical and instrumental analysis including 
toxicological and pharmacological screening.  
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2. AIM AND OBJECTIVES 
Aim 
Researchers have been trying for years to develop new therapeutics and 
therapeutic methods from natural sources to treat asthma. This disease needs a 
prolonged treatment with safe medication and quality living. This could be achieved 
by Siddha system of medicine as it not only treats the disease but also brings the 
overall wellbeing of the human. 
According to the Siddha literature Kadukai vadagam was used for bronchial 
asthma. Thus the aim of this dissertation is to establish the Scientific Validation of the 
Bronchodilator, Anti-Histamine and Anti-Oxidant property of Kadukkai Vadagam 
for Bronchial Asthma. 
Objectives 
The following methodology was adopted to evaluate the safety and efficacy of 
the test drug in this study 
 Collection of various Siddha and modern literature relevant to the study. 
 Preparation of the drug according to the classical Siddha literature. 
 Physicochemical and phytochemical investigation of the test drug. 
 Evaluate bio-chemical analysis of the test drug to derive acidic and basic 
radicals. 
 To estimate the percent of elements, functional groups and particle size 
through instrumental analysis of the trial drug. 
 Evaluation of the Acute and 28 days repeated dose Toxicity of test drug 
according to OECD guidelines. 
 Evaluation of pharmacological study of the drug through the following 
activities   
 Evaluation of Bronchodilator activity  
 Evaluation of Anti- histamine activity 
 Evaluation of Anti -oxidant activity of Kadukkai Vadagam 
 To scrutinize all the above studies to establish the potency of Kadukkai  
   Vadagam  
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3. REVIEW OF LITERATURE 
3.1. Drug Review 
The trial drug “Kadukkai Vadagam” was taken from the Siddha literature 
“Athmaratchamirtha Vaidhiya Saara Sangiragam (part 2)’’ for treating Bronchial 
Asthma. The ingredients of the drug are, 
 Kadukkai (Terminalia chebula)         
 Kalluppu(sodium chloride)   
 Korai kizhangu (Cyperus rotandus)    
 Korochanni omam (Hyoscyamus niger)   
 Chukku  (Zingiber  officinale)                                            
 Kodivelli Ver (Plumbago indica)                                                 
 Thippilli  (Piper longum)     
 Chevuiyam (Piper nigrum)     
 Thippilli molam (Piper longum root)     
 Milagu (Piper nigrum)      
  Induppu (Sodium chloride impura)                      
  Omam (Carum copticum) 
Associated drugs 
 Inji charu (Zingiber officinale) 
 Ezhumichai charu (Citrus limon) 
 Butter Milk 
3.1.1. Gunapadam Aspect 
Kadukkai 
Botanical name  : Terminalia chebula  
Synonyms             : Anthan, Abhayan, Amudham, Devi, Divya, Rohini,  
  Ammai, Abaranam, Aritaki, Varikkai, Jeevandhi 
Vernacular names 
 Tamil       :   Kadukkai 
 English        : Myrobalan 
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 Hindi           : Harre, Harad, Harar 
 Sanskrit : Haritaki, Abhaya, Kayastha, Siva, Pathya 
 Telugu  : Karaka, Karakkaya 
 Kannadam : Alalekai 
Other Varieties : Visayan, Arokini, Prithivi, Amrita,  Sivanthi,  
   Thiruvirti, Abayan 
Part used  : Dried fruit 
Properties 
Suvai (Taste)      : Thuvarppu, Inippu, Kaarppu, Kaippu, Pulippu 
Thanmai (Nature)      : Veppam 
Pirivu (Bio- Transformation):  Kaarppu  
Actions  
 Digestive 
 Expectorant 
 Laxative 
 Appetizer  
 Nutrient 
General characters  
“தாடை கழுத்தக்கி தாலு குறியிவிைப் 
படீை சிலிபதமுற் பபதிமுைம்- ஆடையயட்ைாத் 
தூலமிடி புண்வாத பசாணிகா மாடலயிரண் 
ைாலமிடி  பபாம்வரிக்கா  யால்” 
- அகத்தியர் குணவாகைம். 
Indications 
It cures Jaw, neck, cheek diseases, Filariasis, Diarrhoea, Obesity, Rheumatoid  
Arthritis, Jaundice. 
[8] 
Therapeutic uses  
 Terminalia chebula is used in Asthma, Fever and Urinary diseases. 
 Used as a gargle in sore mouth and Stomatitis, spongy and ulcerated gums. 
 Terminalia chebula is made into a paste by adding some water and is mixed 
with castor oil and applied over the burns and scalds
[9] 
. 
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Kallupu 
Chemical Name: Sodium chloride  
Synonyms         : Kadar kuruvi, Anna koormai, Arusuvai saathi, Uvaruppingunam.
[10]
 
General characters 
“ஐயமறுஞ் சூடல யபராசிபித்தஞ் சத்தியயாடு 
யவய்யபிணி யட்ைகுன்மம் விட்பைகும்- யபய்வடைபய 
வாதமதி தாகம் மலக்கட்டும் பபாமுலகிற் 
பகாதறுகல் லுப்டபக் யகாடு”. 
                                                                                 _     பதார்த்தகுண சிந்தாமணி [10]                         
Indications 
It is effective in the treatment of Kapha, Pricking pain, Loss of appetite, Pitha 
diseases, Eight types of Ulcers, Vatha diseases, Polydipsia and Constipation. 
Korai kizhangu  
Botanical name :  Cyperus rotundus   
Synonyms  :   Muthakasu 
Vernacular names 
Tamil  -  Korai 
English -  Nut grass 
Telugu  -  Tungamuste 
Malayalum -  Muththanna 
Kannadam -  Tangahullu 
Sanskrit -  Mutha 
Part used 
 Rhizome  
Actions 
 Astringent 
 Stimulant 
 Tonic  
 Diuretic 
 Diaphoretic  
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 Demulcent 
 Emmenagogue  
 Vermifuge. 
General properties 
“சீத சுரந்தீர்க்குஞ் யசம்புனல்பித் தம்பபாகும் 
வாத சுரந்தணிக்கும் டவயகத்தில்- பவடதயசய்ய 
வந்த பிணிடயயயல்லாம் வாட்டுமுத் தக்காசு 
யகாந்துலவும்  வார்குழபல! கூறு 
 
அதிசாரம் பித்தம்  அனற்றாகம் ஐயங் 
குதிவாதஞ்  பசாபங் யகாடிய- முதிர்வாந்தி 
யாடரத்  யதாைர்ைந்தாலும்  அவ்வவர்க்யக லாங்குைத்துக் 
பகாடரக் கிழங்டகக் யகாடு” .        
            - அகத்தியர் குணவாகைம் 
Indications 
It cures Fever with rigor, Hypertension, Thirst, Delirium, Diarrhoea, Mental 
illness, Pitha induced thirst, Kapha disease, Calcaneal spur and Vomiting. 
Therapeutic uses                            
 Powdered korai kizhangu taken as rejuvenative purpose for tuberculosis.  
 Decoction of korai kizhangu used for diarrhoea, ulcer and vomiting. 
 Tender korai kizhangu is made into paste and applied over the breast for 
galactogogue action. 
 Preparations made out of korai kizhangu is used in childhood kapha 
diseases.
[8a]
 
Korochanni  Omam 
Botanical name : Hyoscyamus niger 
Synonyms  : Thipiyam, Karapi, Karsavai 
Vernacular names  
 Tamil          : Korochanni omam  
 English        :  Black henbane 
 Hindi           :  Khorasani-Ajowan  
 Sanskrit :  Parasikayavani  
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 Telugu  :  Kurasani oamamu  
 Kannadam :  Kurasani voma  
Part used  :  Seeds 
Properties 
Suvai (Taste)   :  Kaarpu, Sirukaippu 
Thanmai (Nature)             :  Veppam  
Pirivu (Bio- Transformation) :  kaarpu  
Actions  
 Hypnotic 
 sedative  
 Anodyne 
 Antispasmodic 
 Mild diuretic   
General characters  
“யவகுமூத் திரம்வாதம் வரீியநட் ைம்புண் 
உகுபபதி யுட்கடுப்பி பனாபை-மிகுகரப்பான் 
தீராக் கபமிடவபபாம் யசய்யகு பராசானியயன்றால் 
வாரா மயக்கமுற மால்”. 
 - அகத்தியர் குணவாகைம். 
Indications  
It cures dental diseases, Amenorrhea, Dysmenorrhoea, Asthma, Rigor,  
Insomnia, Ulcer, Diarrhoea, Dysentery, Eczema, Kapha disease.  
Therapeutic uses 
 65-320mg hyoscyamus extract is used to treat delirium, insomnia. 
 It has febrifuge action. It reduces the irritation present in colon and lungs.[8b]                         
 Chukku 
Botanical name:  Zingiber officinale 
Synonyms: Nagaram, Atagam, Aartharagum, Chonndi, Chowpannaum, Verkombu,  
       Nava suru, Ullarntha inji, Vidam moodiya amirtham. 
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Vernacular names 
Tamil : Chukku 
English : Dried ginger 
Telugu : Sonti 
Malayalam : Shukka 
Kannadam : Ona shunti or Sunti 
Sanskrit :  Nagaram 
Hindi : Sonth 
Part used  : Dried Rhizome 
Properties   
Suvai (Taste)   : Kaarppu   
Thanmai (Nature)  : Veppam 
Pirivu(Bio-Transformation) : Kaarppu 
Actions 
 Stimulant  
 Stomachic 
 Carminative 
General Characters 
“சூடலமந்தம் யநஞ்யசரிப்பு பதாைபமப் பம்மழடல 
மூலம் இடரப்பிருமல் மூக்குநீர் - வாலகப  
பதாைமதி சாரந் யதாைர்வாத குன்மநீர்த் 
பதாைம்ஆ மம்பபாக்குஞ் சுக்கு ”.  
-   அகத்தியர் குணவாகைம் 
Indications  
            Dried ginger was used for Indigestion, Gastric irritation, Anal diseases, 
Asthma, Cough, Diarrhoea, Sinusitis, Anaemia and Fever.  
Therapeutic uses 
 A pinch of dried ginger powder with cow’s milk is useful in loss of appetite. 
 Dried ginger powder with sugarcane juice reduces burning sensation of the 
stomach. 
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 Dried ginger with sugar candy powder taken with tender coconut in morning 
and evening for dyspnoea and chest pain after heavy working. 
 Dried ginger decoction is useful for poisonous type of fever. 
 Chewing a piece of dried ginger helps in relieving the tooth ache.[12] 
 
Kodi veli Ver 
Botanical name: Plumbago zeylanica  
Synonyms  : Eri, Azhal, Oli, Anichal, Vanni, Chithiram, Akni, Kodivanni,  
                          Elunaa, Vannipariyam, Karunagam, Thikku, Thisainaa. 
Vernacular names 
Tamil          : Kodivelli 
English       :  Ceylon lead-wort 
Hindi          :  Chita,chitra 
Sanskrit     :       Angi-shika  
Telugu     :  Tella-chitra-mulam 
Kannadam  :  Chitra-mula 
Part used     : Root 
Properties 
Suvai (Taste)   :  Kaarpu 
Thanmai (Nature)  :  Veppam  
Pirivu (Bio- Transformation) :  Kaarpu  
Actions  
 Anti-periodic 
 Diaphoretic 
General characters 
“கட்டிவிர ணங்கிரந்தி கால்கள் அடரயாப்புக் 
கட்டிச்சூ டலவகீ்கங் காழ்மூலம்- முட்டிரத்தக் 
கட்டுநீ  பரற்றம் கனத்த யபருவயிறும் 
அட்டுங் யகாடிபவலி யாம்”         
- அகத்தியர் குணவாகைம். 
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Indications 
It cures Tumour, Ulcer, Dropsy, Piles, Sinusitis, Ascites, Abscess, Pricking 
Sensation, Haemorrhoids, Syphilis, Filarial Fever and Septic fever. 
Therapeutic uses  
 A paste formed from kodiveli with gingely oil and is applied over Piles, 
Inguinal bubo and Cervical lymph nodes. It also used to dilate the cervix.  
 A paste formed by grinding the root with milk is used to reduce the effect of 
poisons.
[8c]
 
 
Thippili 
Botanical name: Piper longum  
Synonyms         : Pippli, Aadhi,Kaaman, Sowndi, Kanam, Saram, Koli, Ambu,  
     Aathimarunthu, Kanai. 
Vernacular names  
Tamil  : Thippili 
English            : Long pepper 
Telugu          : Pippilu 
Malayalam   : Thippili 
Kannadam    : Hippili 
Sanskrit       : Pippali 
Hindi           : Pipar 
Part used  : Dried fruit and Roots 
Properties   
Suvai (Taste)          : Kaarppu  
Thanmai (Nature)         : Veppam 
Pirivu (Bio- Transformation): Kaarppu  
Actions   
 Carminative 
 Stimulant 
 Expectorant 
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 Antiseptic 
 Febrifuge     
General characters 
 “கட்டி யயதிர்நின்று கடுபநாயயல் லாம்பணியும் 
 திட்டி விடனயகலும் பதகயமத்த-புட்டியாம் 
 மாமனுக்கு மாமயனன மற்றவர் மற்றவனாங் 
 காமயமனுந் திப்பிலிக்கும் டக”. 
-     பதரன் யவண்பா  
Indications 
It relieves Kapha related diseases and strengthens the body. 
[8d] 
Therapeutic uses 
 Powered long pepper with honey will relieve cough, cold, asthma, hoarseness 
and hiccough. 
 Long pepper powder with honey and betel leaf juice cures fever. 
 A mixture of long pepper, long pepper root, black pepper and ginger in equal 
proportions is used to relieve colic and flatulence. 
 Powered form of long pepper seeds with ghee is used for its aphrodisiac 
action. 
[12a]
 
Chevuiyam  (Milagu Ver) 
Botanical name   : Piper nigrum (Black pepper root) 
Synonyms      : Kandirai, Savigai, Saviyam 
Vernacular names 
Tamil  :  Milagu 
English          :  Black pepper 
Telugu            :  Miriyalu   
Malayalum     :  Kurumilagu 
Sanskrit         :  Maricha 
Hindi            :  Kali-mirch 
Part used        :  Root 
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Properties    
Suvai (Taste)   : Kaippu, Kaarppu  
Thanmai (Nature)  : Veppam 
Pirivu (Bio- Transformation) : Kaarppu  
Actions 
 Carminative  
 Stimulant  
 Anti-vadha 
 Antidote   
General characters  
“சூடல அருகிசன்னி யதால்லிருமல் ஈடைபித்தம் 
பமடலக் குரற்கம்மல் யவங்கைபநாய் –மூலசுரம் 
கவ்வியங்கத் பதறு கனதா வரவிைமுஞ் 
யசவ்வியங் யகாள்ைவிடுந் பதர்”             
                                                                 - அகத்தியர் குணவாகைம். 
Indications 
It cures spasmodic pain, Tastelessness, Chronic fever, Chronic Cough,  
Hoarseness, Throat diseases, Fever.          
Therapeutic uses  
Oil prepared from Cheviyum is used for catarrh. 
[8e]
                                   
Thipilli Moolam 
Botanical name : Piper longum (long pepper root)  
Synonyms                   : Ampinati, Kiranthinadi ver, Kiranthigam, Thippili ,Thippili  
kattai, Nathikaranthai, Narukku vaeru, Narukku  
thippili, Kanda thipppili, Modi ver. 
Vernacular names  
Tamil  : Thippili moolam 
English            : Long pepper- root 
Telugu          : Pippili-mulam 
Malayalam   : Kattu thippili 
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Kannadam    : Hippfli-beru 
Sanskrit       : Pipalee-moola 
Hindi           : Felfelai-maya 
Part used  : Roots 
Properties   
Suvai (Taste)   : Kaarppu  
Thanmai (Nature)  : Veppam 
Pirivu (Bio- Transformation) : Kaarppu  
Action   : Stomachic 
General characters 
“தாகபித்தஞ் பசாகந் தணியாச் சுரமிருமல் 
பமகங் குரற்கம்மல் யமய்க்கடுப்பும் – ஏகுங்காண் 
திப்பிலிமூ லங்கண்ட்த் திப்பிலிய தாம்நறுக்குத் 
திப்பிலியயன் பறயயாருக்காற் யசப்பு”. 
-   அகத்தியர் குணவாகைம் 
Indications 
           It cures Puerperal fever, Cough, Syphilis, Hoarseness, Burning sensation, 
Chronic fever, Diarrhoea and Body pain. 
Therapeutic uses 
 A paste formed by grinding the root with milk is used to treat thirst, back pain 
and vatha disease. 
 Root powder is used as inhaler for angina and Syncope. [8f] 
 Milagu 
Botanical name: Piper nigrum 
 Synonyms        : Malayali, Masam, Sarumabandam, Kayam, Kalinai, Miriyal. 
Vernacular names  
Tamil  : Milagu 
English          : Black pepper 
Telugu            : Miriyalu 
REVIEW OF LITERATURE 
 
BRONCHODIALATOR ACTIVITY OF KADUKKAI VADAGAM  16 
 
Malayalam     : Kurumilagu 
Sanskrit         : Maricha 
Hindi            : Kali-mirch 
Part used        : Dried fruit 
Properties      
Suvai (Taste)   : Kaippu, Kaarppu  
Thanmai (Nature)  : Veppam 
Pirivu(Bio- Transformation) : Kaarppu  
Actions   
 Carminative  
 Stimulant  
 Anti-vadha 
 Antidote 
General characters 
 “சீதசுரம் பாண்டு சிபலத்மங் கிராணிகுன்மம் 
 வாதம் அருசிபித்தம் மாமூலஓது - சன்னி 
 யாசமபஸ் மாரம் அைன்பமகம் காசமிடவ 
 நாசங் கறிமிைகினால்”. 
- அகத்தியர் குணவாகைம் 
Indications 
 It cures Anaemia, Gastric ulcer, Giddiness, Diarrhoea, Dysentery, Vomiting, 
Anal fissure and Cataract. 
[8g] 
Therapeutic uses  
 Dried unripe fruits are prescribed in cholera, dyspepsia, flatulence and various 
gastric ailments. 
 Powdered black pepper with onion and salt is made into a paste, and this 
mixture is applied on the scalp to cure alopecia and also to increase the hair 
growth. 
 Black pepper paste is applied externally for boils. 
 Powder of black pepper is used as tooth powder. [12b] 
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Induppu  
Chemical name  : Sodium chloride impura 
Synonyms    : Sainthavam, Sinthooram, Santhiranuppu, Mathiyuppu, 
 Mathikoormai, Minthaachchol, Sainthalavanam, Mathilavanam. 
Actions    
 Laxative 
 Carminative 
 Diuretic 
 Stomachic 
General Characters  
"அட்ைகுன்ம மந்தம் அசிர்க்கரஞ்சூர் சீதபித்தந் 
துட்ைடவயம் நாடிப்புண் பைாைங்கள் - யகட்ைமலக் 
கட்டுவிை விந்டதயக் காமியபநாய் வன்கரப்பான் 
விட்டுவிை விந்துப்டப விள்." 
-     குணபாைம் தாது சீவம் வகுப்பு 
Indications 
 It cures Gastric ulcer, Constipation and Cough. 
Therapeutic uses: 
 As a Digestive, a compound powder made of Rock salt, Terminalia chebula,  
Phyllanthus emblica and Long pepper in equal parts, recommended in doses of 
10 grains twice a day. 
 Used in the treatment of sprains externally 
 Beneficial in dyspepsia and other abdominal disorders. 
[13]
 
Omam 
Botanical name   : Carum copitum 
Synonyms      : Asamotham, Thipiyam 
Vernacular names 
Tamil          :  Omam  
English        :  The bishops weed 
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Malayalam :  Ayamodakam 
Hindi           :  Ajvayam  
Sanskrit :  Yavani  
Telugu  :  Omamu  
Kannadam :  Voma  
Part used   : Seed 
Properties 
Suvai (Taste)   :  Kaarpu 
Thanmai (Nature)             :  Veppam  
Pirivu (Bio- Transformation) :  Kaarpu  
Actions   
 Stomachic 
 Antispasmodic 
 Carminative 
 Antiseptic 
 Stimulant 
 Tonic 
 Sialogogue 
General characters  
“சீதசுரங் காசங் யசரியாமந் தம்யபாருமல் 
பபதியிடரச் சல்கடுப்பு பபராமல் –ஒதிருமல் 
பல்யலாடுபல் மூலம் பகமிடவபநா யயன்யசயுபமா 
யசால்யலாடுபபாம் ஒமயமனச் யசால்” 
- அகத்தியர் குணவாகைம். 
Indications  
Cough, Diarrhoea, Bronchial asthma, Dental diseases. 
[8h]
  
Therapeutic uses  
 Dose of the oil is from 1-3 drops on sugar or made into an emulsion with 
water .Externally it is applied to relieve rheumatic and neuralgic pain. 
 Oil and the distilled water from the seeds, known as omam water in doses of 1 
to 2 Ounces are useful in the early stages of Cholera. 
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 Oil and flowers of carum copitum combined with soda forms a nice remedy 
for acidity, dyspepsia and flatulence. 
[14]
                                    
Butter milk 
  It is a food habit in Tamilnadu to take rice with butter milk at the end of a 
meal. It prevents constipation and reduces body heat. It also acts as a mild diuretic, 
reduces pain and swelling of the ankles and makes free maturation. Cow
’
s buttermilk 
is better for heavy walkers and hungry persons and persons who are suffering from 
heat. It cures heat and thirst. 
  For patient suffering from leprosy, butter milk is more useful during 
medication, which eliminates toxins along with medicines in the urine. Butter milk is 
used as a best adjuvant and regimen in the diseases of ascites. 
[13a] 
Elumichai 
Botanical name  : Citrus limon 
Vernacular names 
Tamil           :  Elumichai  
English        :   Lime 
Malayalam :   Cheru-naranga 
Hindi          :   Ninbu limu  
Sanskrit :   Jambira  
Telugu :   Nimma  
Kannadam :   Nimbe 
Part used:  Leaf, fruit, fruit juice, oil. 
Properties 
Suvai (Taste)  : Pulippu 
Thanmai (Nature)             : Veppam  
Pirivu (Bio- Transformation): Kaarpu  
Actions  
 Rubefacient 
 Carminative  
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General characters  
“தாகம் குநகபநாய் தாழாச் சிலிபதபநாய் 
பவகங்யகாள் உன்மாதம் வறீுபித்தம் –மாகண்பணாய் 
கன்னபனாய் வாந்தியும்பபாங் கட்டுவா தித்யதாழிலில் 
மன்யனலுமிச் சங்கனிடய வாழ்த்து” 
-   அகத்தியர் குணவாகைம். 
Indications  : Vomiting, Nausea, Dehydration, Psychotic disorder.
 [8i]
  
Therapeutic uses  
 A pickle of this fruit is  popular and effective remedy  
     for indigestion  
 Nimba thailam applied as special usage in leprotic ulcers.[14a]                                
 Inji 
Botanical name : Zingiber officinale 
Synonyms          : Allam, Artharagam, Arthiragam, Ilakottai, Narumaruppu mathil.  
Vernacular names 
 Tamil           :  Inji  
 English        : Green ginger-fresh root of-dry ginger 
 Malayalam : Inji 
 Hindi           :  Adarakh,sonth   
 Sanskrit : Adrakam  
 Telugu    :  Alluma  
 Kannada     : Hashi-shunti,Vona-sunthi 
Part used   : Rhizomes 
Properties 
Suvai (Taste)  : Kaarpu 
Thanmai (Nature)             : Veppam  
Pirivu (Bio- Transformation) : Kaarpu  
Actions   
 Carminative 
 Stomachic 
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 Sialogogue 
 Digestive 
 Stimulant 
 Rubefacient 
General characters  
“இஞ்சிக் கிழங்குக் கிருமல்ஐயம் ஓக்காைம் 
வஞ்சிக்குஞ் சன்னிசுரம் வன்பபதி-விஞ்சுகின்ற 
சூடலயறும் வாதம்பபாந் தூண்ைாத தீபனமாம் 
பவடலயுறுங் கண்ணாய் விைம்பு.” 
-  அகத்தியர் குணவாகைம். 
Indications : It cures Tuberculosis, Cough and Diarrhoea. 
Therapeutic uses  
 Ginger juice mixed with sugar candy and given twice daily is a good 
remedy for diabetes (both types – mellitus and insipidus) 
 12 ml of each ginger and onion juice is mixed together and given helps 
in relieving Nausea and Vomiting.                                     
 Ginger juice rubbed on and around the Umblicus is said to cure all kinds 
of  Diarrhoea. 
[8j]
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3.1.2. Botanical Review 
Kadukkai (Terminalia chebula) 
Scientific classification 
[15]
   
Kingdom : Plantae     
 Class    : Dicot 
 Order  : Mytales 
 Family            : Combretaceae 
 Genus              : Terminalia  
 Species            : chebula 
Occurrence and distribution 
 It was distributed in chiefly in deciduous forests and areas of light rainfall, but 
occasionally in moist forests, up to about 1500 m throughout India. Abundant in 
northern India; also occurs in Bihar, West bengal, Assam.  
Description of the plant 
 A large tree young branchlets, leaf buds and leaves with long, soft, shining, 
rust coloured, sometimes silvery hairs. Leaves are mostly sub-opposite distant, ovate 
or oblong ovate, 8 to 20 cm long, deciduous in the cold season. Flowers dull white or 
yellowish, with a strong offensive smell, borne in spikes from the upper axils and in 
small terminal panicles. Bark 6mm thickness, dark brown with shallow vertical cracks 
wood very hard, brownish grey with a greenish or yellowish tinge. Fruit yellowish -
brown, ovoid, 20 to 55 mm long, 13 to 25 mm wide, wrinkled and ribbed 
longitudinally. Non adherent to the seed taste astringent. 
Chemical Constituents 
 Fruits and bark contains Gallic acid, Terminoic acid, Ferulic acid, Vanillic  
     acid and Tannin.  
 In leaves the characteristic compounds are Tannins, Triterpenes, saponins and 
mucous substances. The tannins are esters of different phenol-carbonic acids. 
 The fruit of Terminalia chebula contains three hydrolysable Tannins, 
Chebulinic acid, Chebulagic acid. 
[16]
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Korai kizhangu (Cyperus rotundus) 
Scientific classification 
Kingdom   :          Plantae 
Class  : Liliopsida 
Order  : Poales 
Family  : Cyperaceae 
Genus :  Cyperus 
Species : rotundus 
 Description 
 It is a perennial, stolaniferous, rhizomatus, halophytic sedge. Rhizome many 
slender, 
 Tuber-white, succulent when young, hard and black when mature; stem-leafy 
at base arising from a tuber. Leaf above dark green, with reddish brown 
sheaths, clustered at the base of stem. Inflorescence 3-9 spreading rays bearing 
tassels of few, large spikelet; spikelet 20-40 flowered, red brown to almost 
black. Fruit shape is oblong ovate. 
Constituents 
α-cyperone, β-selinene, cyperene, patchoulenone, sugeonol, kobusone, and 
isokobusone, that may scientifically explain the folk- and alternative-medicine 
uses. A sesquiterpene, rotundone, so called because it was originally extracted 
from the tuber of this plant 
Part used : Tubers 
Medicinal Uses  
           The root is pungent, acrid, cooling, astringent, appetizer, stomachic, 
anthelmintic and useful in treatment of leprosy, thirst, fever, blood diseases, 
biliousness, dysentery, pruritis, pain, vomiting, epilepsy, opthalmia, erysipelas 
etc.
[17]
  
Inji (Zingiber officinale) 
Scientific classification 
 Kingdom : Plantae 
 Class  : Monochlamydeae 
 Order : Zingiberales 
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 Family  : Zingiberaceae 
 Genus  : Zingiber 
 Species   : officinale 
Occurrence and distribution 
          Inji is the rhizome of Zingiber officinale 
 (Family: Zingiberaceae), widely cultivated in 
 India, rhizomes dug in January- February, buds 
 and roots removed, soaked overnight in water,  
decorticated and sometimes treaded with lime and dried. 
Description 
Macroscopic 
          Drug occurs as entire rhizome or in pieces, rhizome laterally compressed 
bearing flattish ovate, oblique branches on upper side, each having a depressed scar at 
its apex, pieces 5 to 15 cm. Long, 1.5 to 6.5 cm. Wide (usually 3 to 4 cm.) and 1 to 
1.5 cm.thick,fracture short with projecting fibres, transversely cut surface shows a 
wide central stele having numerous greyish cut ends of fibres and yellow secreting 
cells; odour characteristic; taste pungent. 
Microscopic 
            Rhizome – Shows a few layered, irregularly arranged, tangentially elongated, 
brown cells of outer cork and 6 to 12 rows of thin-walled .colourless, radically 
arranged cells of inner cork. secondary cortex consisting of hexagonal to polygonal, 
isodiametric, thin-walled, parenchymatous cells containing numerous circular to oval 
starch grains with characteristic striations and hilum at one end measuring 5 to 25 µm 
in dia., idioblasts containing large yellowish to brownish globules of oleo-resin; walls 
of oil cells suberised; numerous ckised, conjoint, collateral, cortical fibro-vascular 
bundles scattered throughout cortical zone, greater number occurring in inner cortical 
region, larger bundles consists of 2 to 7 vessels, small cells of sieve tube; pericycle 
single layered enclosing central stele; larger bundles found scattered throughout stele, 
composed of xylem, phloem, parenchyma and sheath of sclerenchyma. 
Constituents 
Volatile oil containing cineole, zingiberol, zingiberene, bisabolene and phellandrene, 
gingerdione, dihydro gingerol, dexahydro curcumin and desmethyl hexahydro 
curcumin, dehydro gingerdione. 
[17a]
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Chukku (Zingiber officinale) 
Chemical Constituents  
 α-zingiberene, gingerin, beta-sesquiphellandrene, gingerdione, gingerdiols,   
gingerdiacetates, 6-gingersulfonic acid, gingerol, shogaol, diterpenes, ginger 
glycolipids A,B & C, curcumene, fats and starch. 
[18] 
 
Milagu (Piper nigrum) 
Scientific classification
 [19]
 
Kingdom  : Plantae 
Class       : Dicot 
Order        : Microembryeae 
Family      : Piperaceae 
Genus       : Piper  
Species    : nigrum 
Occurrence and distribution 
The plant cultivated in the hotter and moist parts of India, in evergreen forest 
up to 1,500 meters. 
Description of the plant 
Climbing perennial shrubs, rooting at the nodes, leaves are cordate or round 
based; flowers minute in spikes usually dioeciously. Fruiting spikes very variable in 
length, fruits ovoid or globose one seeded berries, bright red when ripe, seeds are  
globose, albumin hard and testa thin greyish-black to black, perisperm hard, wrinkled 
and white, 0.4 to0.5 cm in diameter; odour aromatics, taste pungent.  
 Flowering occurs in the rainy season and fruits ripening in the autumn season 
(December to April) 
[20]
. 
Chemical Constituents 
 Piperine, chavicine, Piperettine, Piperoline A&B, Trichostachine, N-trans-
feruloyl piperidine, Feruperine, Citrohellol, Arginine, Piperolic acid, Serine, Ascorbic 
acid, Carotene
[9a]
 . 
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Milagu Ver (Piper nigrum) 
Chemical Constituents 
 Piperin, piperlatin, brachyamideA and B, brachystine,sterols. 
[21]
 
Thippili (Piper longum) 
Scientific classification
 [22]
  
Kingdom   : Plantae 
Class        : Dicot 
Order        : Microembryeae 
Family      : Piperaceae 
Genus      : Piper 
Species    : longum 
Occurrence and distribution 
    This plant mostly occurs in hotter parts of the India from central Himalayas 
to Assam up to lower hills of the west Bengal and evergreen forests of western Ghats 
as wild and also cultivated  in north east and south. It grows in Kurinjinilam. 
Description of the plant 
  A slender aromatic climber and leaves alternative, lower ones broadly ovate 
cordite, upper ones oblong, oval, all entire 5 to 7 nerved leaves; male spikes longer, 
slender, 2.5 to 7.5 cm long. Female spikes short, cylindrical, 1.5 to 2.5 cm long, 5 to 
7 mm thick. Fruit greenish- black to black, cylindrical, 2.5 to 5 cm long and 0.4 to 1 
cm thick, consisting of minute sessile fruits, arranged around an axis. Surface rough 
and composite; broken surface shows a central axis and 6 to 12 fruitlets arranged 
around an axis. Odour is aromatic; taste is pungent producing numbness of the 
tongue
 [20a]
.  
Chemical constituents 
Piperine, piperidine, Piperlongumine, Pipernonaline, Sesamin, 
Piperundecalidine, Futoamide, Piplasterol, Volatile oil
 [23]    
.Pellitorine, Piplartine
[24]
.  
Thippli moolam (Piper longum) 
Chemical constituents 
Piperine, sitosterol, cepharadiones. 
[25]  
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Induppu (Sodium chloride impure) 
Chemical Formula :  NaCl (impure sodium chloride) 
Vernacular Names 
English : Rock salt, Sea salt, Bay salt, Sodium chlorate 
Hindi  : Sendhalon, sedhalon 
Malayalam : Intu-Uppu 
Sanskrit : Saindhava 
Telugu  : Saindhalavanam 
Tamil   : Indu-Uppu 
Characters 
 Found in small white crystalline grains or transparent cubes.  
 Brownish white externally and white internally.  
 It is a soluble compound having a characteristic salty taste. 
 Pure salt – colourless and transparent, but often variously coloured as tinged  
 grey or blue or brown or pink due to impurities. 
Specific gravity 
2.1 – 2.6 
Composition of Rock salt (% dry basis) 
Sodium chloride  -   68.85 
Manganese chloride   -   0.55 
Calcium chloride -   0.53 
Magnesium chloride -   0.43 
Sodium bicarbonate  -   0.74 
Insoluble matter        -   30.34 
Moisture  -   1.54 
Solubility 
 35.7 g/100g of water at 0ºC 
 39.8 g/100g of water at 100ºC 
Actions 
 Rock salt possesses stronger purgative properties than Cream of Tartar. 
 Laxative – dosage : 4.2 to 8.4gm 
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 Purgative – dosage: 16.8 to 21gm 
 Carminative  
 Diuretic 
 Stomachic. [26] 
Kodi veli (Plumbago zeylanica) 
Synonyms  
 Plumbago viscosa   
Common names 
  Ceylon lead word, Doctor bush, Plumbago 
Etymology 
 The generic name Plumbago is derived from the Latin plumbum, lead.  
 The specific epithet zeylanica is from the Latinized name for Sri Lanka 
(Ceylon). 
Scientific Classification 
Kingdom  :  Plantae 
Class         :  Magnoliopsida 
Order        :  Plumbaginales 
Family      :  Plumbaginaceae 
Genus      :  Plumbago L. 
Species     :  zeylanica 
Distribution 
             It is a perennial herb distributed widely in India, much cultivated widely in 
the peninsular regions, probably in Bengal, Malay, Peninsula, Ceylon, tropics of the 
world. 
Description 
Macroscopic Characters 
             Mostly perennial shrubs of about 60-120 cm in height. Leaves alternate, 
ovate, acute, glabrous, entire, short stalk, flowers white, bracteates, glandular and 
elongated spikes, 10-30 cm long. Seeds oblong shaped. Roots 30 cm or more in 
length, 6 mm or more in diameter as also as short stout pieces, including root stocks 
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reddish to deep brown, bark thin and brown, internal structure striated, odour, 
disagreeable, taste, acrid. 
[27]
  
Microscopic Characters
 
           Transverse section of root shows outer most tissue of cork consisting of 5 -7 
rows, secondary cortex consists of 2-3 rows of thin walled rectangular, light brown 
cells, starch grains. Secondary cortex followed by a wide zone of cortex is composed 
of large polygonal parenchymatous cells varying in size and shape, containing starch 
grains and some cells with yellow contents, fibres scattered singly or in groups 
consisting of usual elements and phloem fibres, similar to cortical zone, phloem fibres 
usually in groups of 2-5 or more but occasionally occurring singly, lignified with 
pointed ends and narrow lumen,       cambium indistinct, xylem light yellow to whitish 
radically arranged, 1-6,  seriate, radically elongated, starch grains, stone cells absent. 
Constituents 
            Plumbagin, citranone, elliptone, ß-sitosterol-glucoside, bakuchiol, phenols, 
isoaffinetin, saponaretin, flavanoids, psorealen, iso-orientin. 
[28] 
Korochanni Omam (Hyoscyamus niger)  
Scientific classification 
[29] 
Kingdom : Plantae  
Class    :   Magnoliopsida           
Order  :  Solanales  
Family            :  Solanceae  
Genus             :   Hyocyamus  
Species           :   niger  
Occurrence and distribution 
  Kashmir to garhwal, from 2,400m to 3,300m. 
Description of the plant 
 An erect, foetid, viscidly hairy annual or biannual up to  1.5 m in height, 
radical leaves spreading ,coarsely dentate to pinnately lobed, stem leaves smaller, 
ovate, irregularly pinnatified,  flowers yellowish green, veined with purple darker in 
the centre, lower ones in forks of the branches. Upper solitary in the axils of leaf-like 
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bracts, fruits capsules, enclosed in globose enlarged calyx, seeds numerous, minute, 
kidney shaped, brown. 
[30]
   
Chemical Constituents 
 Hyoscine, hyoscyamine, oleic and linoleic acids, N-trans - feruloyl tyramine, 
cannabsin  D, cannabsin G, vanillic acid, hyoscyamide, rutin. 
[31]
  
Omam (Carum copticum) 
Scientific classification 
[32] 
Kingdom :  Plantae  
Class    :   Magnoliopsida     
Order  :   Apiales  
Family            :   Apiaceae  
Genus             :  Carum 
Species           :  copitum  
 
Occurrence and distribution 
  Cultivated throughout India.    
Description of the plant 
 An erect branched annual herb, stems striate, leaves 2-pinnate, ultimate 
segment all linear, flowers pure white in compound umbels, fruits ovoid, ultimately 
shining, yellow, aromatic cremocarps, mericarps with faint ridges, compressed. 
[33] 
Chemical Constituents  
 Thymol, gamma- terpinene, p-cymene. 
[34]
 
Kalluppu (Sodium chloride impure) 
Chemical Name         : Sodium chloride impura  
Chemical Formula    : NaCl (impure sodium chloride) 
Characters 
 Black salt is type of rock salt. It is also  
known as Himalays black salt. The condiment is  
composed largely of sodium chloride with several  
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other components lending the salt its colour and smell. The smell is due to its sulfer 
content. Because if the presence of iron sulfide it forms brownish pink to dark violet 
translucent crystals when whole and when ground into a powder it is light purple to 
pink in colour. 
Composition of black salt 
 It consist primary of sodium chloride and trace impurities of sodium sulphate, 
sodium bisulfide, sodium sulfide, iron sulphide. 
 Unrefiend sea-salt contains small amounts of magnesium and calcium halides 
and sulphates and sulphates traces of algae products, salt resistance bacteria and  
sediment particle. 
[35] 
 Ezhumichai (Citrus limon)  
Scientific classification 
[36] 
Kingdom :  Plantae 
Class    :  Magnoliopsida      
Order  : Sapindales  
Family            :  Rutaceae  
Genus              : Citrus  
Species            :  limon 
Occurrence and distribution 
  Throughout India, cultivated in plains and hills in areas up to 1,200m 
elevation. 
Description of the plant 
 A much branched thorny shrub with spreading branches, leaves unifoliately 
compound, rachis winged, leaflet elliptic-oblong, alternate, coriaceous, entire or 
crenulate, flowers white in short racemes, fruits large, globose berries with thick or 
thin rind, pulp pale, very acid. [37]   
Chemical Constituents 
 Polyphenols, terpenes, tannins, citric acid. 
[38] 
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Morden aspect of buttermilk 
 Buttermilk is made by reintroducing lactobacillus  
acidophilus, the probiotic bacteria that gives buttermilk 
 its sour taste. 
            Buttermilk contains a wide range of vitamins  
and minerals, including calcium, iron, magnesium,  
potassium, phosphorus, sodium and zinc. 
[39] 
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3.2. Disease Review 
3.2.1. Siddha Aspect of the Disease 
 Swasakaasam (Bronchial Asthma) 
Other names  
 Iraippu 
 Izhuppu noi 
 Swasam 
 Thoivu 
 Eelai 
 Suram 
 Iraippirumal 
Nature of the disease 
Swasakasam arises with severe chest tightness leading to difficulty in 
inspiration and expiration of the air (i.e. dyspnoea).   In addition to difficulty in 
breathing while exhaling the air, expiratory noise will be produced resembling the 
sounds of musical instruments like flute, veena, lute etc., are heard obviously. Further 
if hard attempts are made to expel the phlegm, it results in vain. 
Genesis of the disease 
          “கால்பெருக் குணவுபொருள் தண்ணரீ் மாறல் 
      கருதிருமல் மிகல்வாந்தி குளிர்ந்த காற்று 
மால்பெய்து நாள்ததாறும் வருந்துங் காய்ச்ெல் 
     மந்தன முயிர்நிலை யிைடிகள் தாங்கல் 
ஏல்ெீத தெதிவிட ொண்டு புலககள்  
      இைகிய பநல்ைாதிமணிச் சுலனயுட் பெல்ைல் 
தமல்வழியிற் ெிைவரினு மிலைப்ொம் தநாயு 
       முனிவர்கள் விளம்ெினாதை” 
                                 - லகபயழுத்துப்ெிைதி 
Swasakasam is caused due to the following factors such as 
 Ingestion of allergic food stuffs  
 Allergy inducing activities such as exposed to cool climates. 
 Immunity deprivation 
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 In take of diet which increases kapha. 
 Grass, rice and ragi also triggers the sign and symptoms 
 Symptoms may also develop due to inhalation of foul smelling substances. 
Prodromal symptoms 
“மார்ெில் விளாவிைண்டில் மண்ணுமிகு  பநரியில் 
தெர்ந்து வைித்தல் திணறல் - தார்மூச்சு  
உப்ெல் வயிற்று லுருவது முற்குறியாச் 
பெப்ெிலைப்பு  தநாய்க்குதலனத் ததர்”  
- யூகி லவத்திய ெிந்தாமணி[40] 
Generally the prodromal symptoms and intensity of the disease will be 
recognised earlier by chronic asthmatics. While taking unsuitable food and while 
inhaling the chill air the patient develops rhinitis, sneezing, chest discomfort, chest 
tightness, pain, difficulty in normal breathing, pain in para vertebral region with 
dyspnoea, distension of abdomen and excess sweating.  
Types of swasakasam 
Swasakasam (Iraippu) has been classified into 5 types. 
Of these, first four types are based on kuttram and the final one is based on intensity 
of breath. They are as follows 
1. Vali Iraippu 
2. Iya Iraippu 
3. Iyavali Iraippu 
4. Mukkutra Iraippu 
5. Melnokku Iraippu 
Apart from this further it is also classified into another 5 types. 
“ெிறுதெ றிலைப்பு திணறல் மந்தாைம் 
வருதம ைிலைப்புந் தின்மாண்பு”  
- யூகி லவத்திய ெிந்தாமணி[40] 
They are as follows 
1. Sittru Iraipu 
2. Per Iraippu 
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3. Thinaral Iraippu 
4. Mandhara Iraippu 
5. Mael Iraippu 
Signs and symptoms 
“வன்லமயாய் தகாலழகட்டி இருமி வழீும் 
  மாநாகம் தொைதவ வாங்குஞ் சுவாெம் 
திண்லமயாய்ச் தெருமலுண்டா மடிக்க டிக்குஞ் 
     ெீைண மிைாமதை வயிறு மூதும் 
நன்லமயாய் நாெியது தணல்தொ ைாகும் 
     நைிந்துடம்பு வற்றி வருங் குைலுங் கம்மும் 
உண்லமயா யுண்ணாக் கிலூறுங் தகணி 
   யுழந்துதம சுவாெகா ெத்தி பனாப்தெ” 
- யூகி லவத்திய ெிந்தாமணி[40a] 
Vali iraippu noi  
Vatha dosha gets aggravated due to ingestion of food that is not easily 
digested, wandering under hot sun rays, eating tubers. Due to increased vatha dosha   
the patient may feela condition as if nothing is inside the chest. Inspite of all these 
conditions patient doesn’t experience severe illness and this condition is curable. Vali 
iraippu is also mentioned as “Soothira swasam”. 
Kabha swasam  
Kapha swasam is caused due to increased kapha dosha because of taking 
foods which increase kapha and also roaming in chill air. It produces nasal 
congestion, rhinitis, chest tightness, inability to breathe. 
Sometimes constricted type of chest pain may aggravate to the extent as if the 
patient dies of inability to breath. When the patient mildly attempts to cough and 
expectorates some mucus relief occurs for some extent. When the patient does not 
cough and expel the mucus dyspnoea occurs and patient is unable to lie on bed, makes 
him to stand. 
Sweating on forehead, blackening of face, chillness of limbs, dryness of 
tongue, shivering of body, dyspnoea, inability to sleep are the associated symptoms of 
this disease. It is also known as ‘Thamaraga suvaasam’. 
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Iyavali iraippu   
In this condition both kapha dhosam and vatha dhosam are dearranged 
together and causes the following symptoms. Symptoms of this type will be very 
severe and the derangement of vatha dosha combines along with udhana vaayu. 
Clinical features of this type are dyspnoea, inability to inspirate and expirate air, 
constipation, abdominal distension, dryness of tongue, redness and painful eyes, 
shivering of body, giddiness, excessive sleep, incoherent talk, etc., this condition is 
also called as “Vichinna Swasam”. 
Mukkuttra iraippu  
In this condition, all the three doshas gets deranged at once and udhana, 
abanan, viyanan, samanan get deranged one by one which in turn affects the seven 
major elements of the body. It is life threatening type of asthma. The prodromal 
symptoms are Shivering of body, dyspnoea, depression, breathing like cow’s 
breathing, chest tightness and pain, constipation, oliguria, pain all over the body, 
stammering and excessive sweating over the forehead. This is also called as “Thinaral 
Iraippu”. 
Maelnokku Iraippu 
If any of the above mentioned disease continues for many days without 
response to treatment, then the upward directional udhana vaayu loses its strength and 
in such a situation, expiration may not be possible. The patient tends to develop 
dyspnoea with prominent eyeball. There may be dryness of mouth. Patient may be 
unable to speak; he may appear astonished and will not lie down on the bed he may 
look upward he may also attempt to exhale by his opened mouth. If proper treatment 
is given at this stage he may survive. Otherwise he may fall unconscious with 
darkening of face and may die with mouth open 
[41]
.  
Other factors affecting the disease 
 Eating foods which will induce excessive kapha. 
 Exposure to chill air. 
 Living in the mountains. 
 Walking in the cold climate. 
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Pulse 
“கெமல்ைாது காெ சுவாெம் வாைாது”[7]  
 Kaba Nadi 
 Vathakaba Nadi 
 Kapthpitha Nadi are the classical pulse for Swasakasam. 
Sputum 
 If the sputum is found excessive in quantity, light weight and foamy, it is 
considered that the disease gets developed due to Kapha dosham. 
 If the sputum is black in colour, hard and with smell of flesh, it will denote 
Kapha dosham. 
 If it is found white like pus and mixed with yellow colour, it will denote Pitha 
dosham
[42]
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3.2.2. Modern aspect of the disease                                      
Bronchial asthma 
Introduction 
Asthma, the word was derived from Greek word. The term “ASTHMA” in 
Greek means breathless or breathe with open mouth. 
Asthma is defined as a chronic inflammatory disorder of the airways, 
characterised by reversible airflow obstruction causing cough, wheeze, chest tightness 
and shortness of breath. 
Inflammation of the bronchial wall involving eosinophil, mast cells and 
lymphocytes, together with the cytokine and inflammatory products of these cells, 
induces hyper-responsiveness of the bronchi so that they narrow more readily in 
response to a wide range of stimuli. Narrowing of the airway in usually reversible, but 
in some patients with chronic asthma the bronchial wall inflammation may lead to 
irreversible obstruction of airflow.
 
Epidemiology  
The prevalence of asthma increased steadily over the later part of the century 
first in the developed and then in the developing countries. Current estimates suggest 
that asthma affects 300 million people world-wide and additional 100 million persons 
will be diagnosed by 2025.In India,15-20 millions are asthmatics.About 2, 50,000 
annual deaths.
 
 Epidemiological studies suggest that the multiple genetic and environmental 
factors contribute to the causation of asthma, a clinical condition that is viewed as a 
cluster of related disorders to smooth muscle hypertrophy. 
[43]
  
Factors that triggers asthma 
 Smoking 
 Infections like cold 
 Allergens such as food, pollens, dust mites and pet dander 
 Exercise 
 Air pollution and toxins 
 Emotional stress and anxiety 
 Weather, especially extreme changes in temperature 
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 Drugs (such as aspirin, NSAID and beta blockers) 
 Perfumes and fragrances 
 Acid reflux 
Allergens are the most causative factor for 50 to 70% for adults in asthma. In 
children under 3 years of age, viral infections (respiratory syncytial virus) are the 
most common trigger. After 3 years of age, the allergies also begin to play an 
increasing role as a trigger. After 20 years of age, occupational exposure to any toxic 
substances and allergens also can be important triggers. 
Dietary deficiency of antioxidants may predispose to development of asthma 
from childhood days
 [44]
 
Pathology 
 Inhaled allergens stimulate sensory nerve endings called irritant receptors 
lying below the airway epithelium.  
 Stimulation of these irritant receptors causes parasympathetic nerves to release 
acetylcholine (ACh). When acetylcholine binds to M3 muscarinic receptors on 
airway smooth muscle, a series of events is initiated which results in an 
increase in intracellular calcium and smooth muscle contraction (broncho 
constriction or bronchospasm). 
 Some inflammatory mediators such as histamine can also increase intracellular 
calcium and cause bronchospasm. 
 Inflammation of the airways is brought on the several factors like eosinophil, 
T-lymphocytes (CD4+), macrophages, and mast cells infiltrate the bronchial 
wall. 
 The epithelium is vacuolated and the ciliated cells desquamate. Several 
cellular factors play their roles in the inflammatory process. 
 Neuropeptides such as bradykinins, substance P and neurotension are lead to 
broncho constriction and excessive secretion of mucous. 
 Mast cells initiate the response on exposure to allergens, excessive osmatic 
changes and variations in temperature. 
 Macrophages produce cytokines, which are either broncho constriction or 
bronchodilator. Presence of eosinophil in the inflammatory exudate is 
characteric of asthma.  
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 Eosinophils are derived from bloodstream. Major basic proteins and cationic 
proteins of eosinophil lead to destruction of mucosal surface.  
 T-lymphocytes, especially CD4+ produce cytokines IL-3,IL-4, IL-5 and GM-
CSF which modify the inflammation.  
 TNF which is an inflammatory cytokine is expressed in greater amounts by 
mast cells. The bronco-alveolar secretions contain higher levels of TNF. 
 Possibly platelet derived humeral factors also modify the inflammation. 
 The main chemical transmitters, which alter the airways, are histamine, 
prostaglandin and leukotriene. These lead to contraction of bronchial muscle, 
increase in vascular permeability and excessive secretion of abnormal mucous. 
Airway inflammation persists for several years. Its severity correlates with the 
severity of asthma. Hyper responsiveness of the inflamed airways is 
aggravated by autonomic and neural mechanisms.  
 The final result is obstruction of the small and medium sized airways brought 
about by mucosal oedema, tenacious mucous and broncho constriction. 
[23]
 
Classification 
Bronchial asthma classified into 2 groups 
Extrinsic asthma (Atopic) 
Intrinsic asthma (Cryptogenic) 
Extrinsic  
 IgE was raised at least 70%  
 Atopic subjects  
 Onset was early (10-15 years) 
 Intermittent in nature  
 Family history of atrophy 
Intrinsic 
 IgE was normal or low 
 Usually Non-atopic subjects   
 Onset in middle age (30years) 
 Constant in nature 
 Family history of asthma.[13] 
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Clinical Features 
Asthma classically displays a diurnal pattern, with symptoms and lung 
function being worse in early morning. 
Typical symptoms are 
 Recurrent episodes of wheeze 
 Chest tightness 
 Breathlessness 
 Sometimes Cough 
Cough may be a dominant symptom in some asthmatic patients and the lack of 
wheeze or breathlessness may lead to a delay in reaching the diagnosis of called 
“cough variant asthma”. 
The classical aspirin-sensitive patient is female and presents in middle age with 
asthma, rhino-sinusitis and nasal polyps. Aspirin sensitive patients may also report 
symptoms following alcohol (white wine) and foods containing salicylates. 
Diagnosis 
 Diagnosis of bronchial asthma is clinical. The history of sudden attack of 
paroxysmal dyspnoea, cough and auscultator hallmark of expiratory wheeze 
heard all over the chest are diagnostic.  
 Long duration of complaints history of allergy and positive family history are 
other helpful clinical points.  
 Objective assessment of the severity of airways obstruction and response to 
broncho dilator therapy can be made by use of bedside peak flow meter. 
 Respiratory function tests reveal gross reduction in FEV1, FEV1/FVC ratio 
and PEFR and increase in the time taken for forced expiration.  
 It is important to assess the severity of airways obstruction. Confirmation of 
the diagnosis of asthma is usually achieved by serial PEFR monitoring. PEFR 
in the majority of cases shows a diurnal variation of more than 15 % and 
improvement with therapy.  
 When it is necessary to investigate for provocative factors bronchial challenge 
testing or BPT may be desirable. 
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Clinical features which indicate severe ventilator impairment are 
1. Inability to narrate history continuously or severe distress even on mild 
exertion 
2. Cyanosis, flapping tremors 
3. Mental confusion 
4. Respiratory rate above 25/min 
5. Heart rate persistently above 110/min  
6. Inspiratory fall in blood pressure exceeds 16 mm Hg 
7. PEFR less than 40 % of predicted value  
8. Feeble breath sounds 
Differential diagnosis 
 Chronic bronchitis 
 Cardiac failure 
 Pulmonary embolism 
 Pulmonary eosinophilia 
 Metabolic acidosis 
 Emphysema 
 Foreign body aspiration.[45] 
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3. 3. Pharmaceutical review 
Vadagam 
Definition  
 Vadagam is similar to pills but larger in size. They are made by grinding with 
water or  juice and then made into vadagam. 
Equipment required 
1. Mortar and pestle 
2. Trays for handling powders and pastes of the drug and for drying the 
vadagam 
3. Vessels and spoons for preparation of juices. 
Method of preparation 
 They preparation of vadagam includes various processes like extraction of 
juices making decotions, preparing powders grinding paste and rolling into vadagm. 
Storage  
 They should be stored in tightly stoppered glass, tin containers sealed.  
[46]
  
Shelf life of medicines 
             Medicines can be classified into internal and external medicines .They are 
each in 32 types. Vadagam comes under the category of internal medicines. The shelf 
life of medicines indicates the potency of medicines. The medicine even though 
seems to be fresh is not efficacious after sometime. So the medicines should not use 
after certain period. 
               As per Siddha literature Agamarunthu padal in Gunapadam Thathu-seevam 
text, 
“உயர்சூர ணம்பிட்டு வடகம் வவண் வணய்நான்கி 
   னுயிர்மூன்று திங்களாகும்…..”   
From the above quote, the shelf life of vadagam is 3 months.
 [47] 
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Table1:-Testing parameters for Vadagam -AYUSH guidelines 
[48] 
  
S.No Tests 
  1 Description, Colour, Odour 
  2 Weight Variation 
  3 Disintegration Time (Not more than 15 minutes) 
  4 Identification TLC/ HPTLC/GLC 
  5 Assay 
  6 Test for heavy / toxic metals 
Mercury 
Arsenic 
Cadmium 
Lead 
    7 
Microbial Contamination 
Total Bacterial count 
Total Fungal count 
     8 
Test for specific pathogen 
E.coli 
Salmonella species 
Pseudomonas aeruginosa 
Streptococcus aureus 
    10 Test for aflatoxins B1, B2, G1, G2 
Morden aspect of lozenges 
Lozenges are solid preparations that are intended to dissolve or disintegrate 
slowly in the mouth. They contain one or more medicaments usually in a flavoured, 
sweetened base. Lozenges are most often used for localized effects in the mouth. 
They can also be used for systemic effect if the drug is well absorbed through the 
include phenol, sodium phenolate, benzocaine, and cetylpyridinium chloride. Newer 
drug include analgesics, anesthetics, antiseptics, antimicrobial, antitussives, anti- 
nausants, and decongestants. 
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Lozenges have the advantage of: 
1. Being easy to administer to pediatric and geriatric patients. 
2. Having formulas that are easy to change and can be patient specific. 
3. Keeping the drug in contact with the oral cavity for an extended period of 
time. 
Disadvantage 
One disadvantage of using a 
“
gummy- type” lozenge with children is they may 
perceive it as candy and not a serious dosage form. 
             Lozenges can be made by molding or by compression. The name troche is 
applied to compressed lozenges. But in lay language, lozenge and troche are used 
interchangeably. Commercial lozenges are made by compression, they are harder than 
ordinary tablets so they will slowly dissolve or disintegrate. Compound lozenges can 
be prepared by molding mixtures of ingredients containing: 
 Sugars to form a hard lozenges 
 Polythylene glycol(PEG) to form a soft lozenge 
 Gelatin to form a chewable lozenge[49] 
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3.4. Pharmacological review 
Bronchodilator drugs used 
 A bronchodilator is a substance that dilates the bronchi and bronchioles, 
decreasing resistance in the respiratory airway and increasing airflow to the 
lungs.  
 Bronchodilators may be endogenous (originating naturally within the body), or 
they may be medications administered for the treatment of breathing 
difficulties.  
 They are most useful in obstructive lung disease of which asthma and COPD 
are the most common conditions. 
Types of bronchodilator drugs 
 Bronchodilators are either short-acting or long acting. Short-acting 
bronchodilators are used for relief of bronchoconstriction, while long-acting 
bronchodilators are predominantly used as preventers. 
             There are three types of bronchodilators namely 
1. β2-agonists (short and long-acting) 
2. Anticholinergic (short and long- acting) 
3. Theophylline (long-acting) 
1. β2-agonists 
(a) Short-acting β2-agonists  
 This medication is providing quick or “rescue” relief from acute 
bronchoconstriction.  
 These medications usually take effect within 20 minutes or less, and can 
last from 4 to 6 hours.  
 These inhaled medications are best for treating sudden and severe or new 
asthma symptoms.  
 Taken 15 to20 minutes ahead of time, these medications can also prevent 
asthma symptoms triggered by exercise or exposure to cold air. 
Examples: 
Salbutamol, Levosalbutamol, Pributerol, Terbutaline, Epinephrine, Ephedrine.  
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(b) Long –acting β2- agonists  
 These are long term medications taken routinely in order to control and 
prevent broncho constriction.  
 These medications may take longer to begin working, but relief airway 
construction for up to 12 hours.  
 Commonly taken twice a day with an anti-inflammatory medication, they 
maintain open airways and prevent asthma symptoms, particularly at night. 
Examples 
Salmeterol, Fenoterol, Pirbuterol, Clebuterol, Formoterol, Bambuterol, 
Indacaterol
[50]
  
(2) Anticholinergics 
 Anti cholinergics or Anti muscarinic drugs relax the smooth muscles but 
response is slower than Beta-2 agonist.                
 Some examples of anticholinergics are Tiotropium bromide and 
Ipratropium bromide. 
 Tiotropium bromide is long acting, a single inhalation can have effect 
lasting for 24 hours. It reduces the frequency and severity of episodes. 
 Ipratropium bromide is short acting, given by inhalation which has effect 
for 4-6 hours.  
(3) Theophylline 
 Theophylline is long acting bronchodilator that prevents asthma episodes.  
 Available in oral and injectable form. 
 It is prescribed in severe cases of Asthma or those that are difficult to 
control. 
 This medication must be taken 1-4 times daily and doses should not be 
missed. 
Blood tests are required to monitor therapy and to indicate when dosage 
adjustment is necessary
 [51]
 
MECHANISM OF ACTION OF BRONCHODILATOR DRUGS 
 Beta-2 agonist drugs bind to beta-2 receptors on airway smooth muscle  
relaxation. When airway smooth muscle relaxes, the diameter of the air 
passages is enlarged.  
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 Bronchodilator drugs blocks the action of phosphordiesterases and prevents  
the breakdown of cAMP to 5-AMP. This also has the effect to relaxing smooth 
muscle and allowing the airways to dilate.  
 The bronchoconstriction effects of acetylcholine can be blocked by muscarinic 
antagonists. Muscarinic antagonists bind to muscarinic receptors and prevent 
acetylcholine from binding.  
Bronchodilator can also be achieved by alpha-2 agonist drugs that bind to alpha 2 
receptors on parasympathetic nerves and prevent acetylcholine from being 
released
 [52]
  
Pharmacological study in animal models 
Bronchodilator activity 
In vitro methods 
Spasmolytic activity on guinea pigs isolated tracheal chain  
The isolated tracheal chain of guinea pigs can be used for testing compounds 
which inhibit bronchospasm. It detects sympathomimetic, H1-histamine receptor 
antagonist properties of test drug. 
Methodology 
 Guinea pig of either sex weighting between 300-500 g are sacrificed using 
ether anaesthesia. The entire trachea is dissected out and cut into individual rings. 
Twelve to fifteen rings are tied together with silk threads and mounted in the organ 
bath containing Krebs-Henseleit solution and maintained at 37
o
C, under a tension of 
0.5 g and gassed with carbon. Isometric contractions are recovered via a strain gauge 
transducer on a polygraph. Forty five minutes are allowed for equilibration before the 
addition of the spasmogen. The following spasmoegns used Histamine, Carbachol, 
LTC4 or LTD4. It takes about 10-12 min for reaching the contraction to a maximum. 
At this stage, standard and test drugs are administered. The bronchial response is 
allowed to plateau and recorded. The tissue is rinsed thoroughly and the control 
contractions are induced again by adding spasmogen. The percent inhibition of 
spasmogen induced contractions is calculated. From dose response curve ED50 is 
calculated
 [53]
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Isolated Frog Rectus Abdominis Muscle Preparation 
 A frog is pithed and laid out on frog dissection board. The skin of the anterior 
abdominal wall is cut by a midline incision which is extended laterally up to the 
anterior aspects of the limbs. This exposes the flat whitish muscle of the anterior 
abdominal wall from their pubic origin to their sternal insertion. The two recti are 
removed and placed in frog ringer solution in a shallow dish. They are carefully 
cleaned and one of them is trimmed to the desired size and mounted in an organ bath 
of 5ml capacity, at room temperature, aerated with oxygen. For recording purposes, 
an isotonic lever with a sideways writing point is used tangential to the smoked drum, 
balanced for a tension of 2.5gm with an extra load of 1gm on the long arm. A 
standard solution of Ach is added to the bath and a slow contraction is recorded on the 
slow moving drum for exactly 90sec. The drum is stopped and the bath fluid is 
replaced by fresh Frog-Ringer. An extra 1gm load is used to extend the muscle to its 
original length.
 [54]
 
In vivo methods 
Histamine induced bronchospasm in guinea pig 
Guinea pigs subjected to inhibition of aerosols containing histamine or other 
bronchospasm inducing agents, exhibits the symptoms of asphyxiating convulsions 
resembling acute attack of bronchial asthma. These challenging agents are 
administered in the form of aerosols through a nebulizer to individual guinea pigs 
placed in a histamine chamber. The initial symptoms are increased frequency of 
breathing, forced breathing and finally asphyxiating convulsions. The occurrence of 
these symptoms can be delayed by antagonistic drugs and bronchodilators. Pre-
convulsion time is noted as the end point. 
Methodology 
 Male guinea pigs weighing around 400 g are used in groups of 8-10 animals. 
The animals are treated with test / standard drugs orally or subcutaneously. The 
animals are then placed in the standard Histamine chamber, 30 min after the 
administration of drug and exposed to an aerosol of 0.1 % solution of histamine 
dihydrochloride through a nebulizer. Time required for the onset of asphyxiating 
convulsions is recorded. The animal is immediately withdrawn from the inhalation 
box and placed in a well-ventilated area for revival from the convulsions. This method 
REVEIW OF LITERATURE 
BRONCHODIALATOR ACTIVITY OF KADUKKAI VADAGAM  50 
has been further improvised using an ultra-sound nebulizer which provides the steady 
exposure to histamine solution at a pre-determined rate. Percent of increase of pre-
convulsion time is calculated from the average values of treated and control groups of 
guinea pigs. ED50 values denoting 50% increase in the pre-convulsion time can also 
be calculated. Histamine aerosol exposure is a very commonly used and dependable 
method for screening the bronchodilator activity of novel compound.
[55] 
Egg albumin induced anaphylaxis in guinea pig 
Guinea pig was sensitized by two intra peritoneal injections of 0.5 ml and 10% 
w/v solution of egg albumin at a 48 hours interval. After sensitization, the animals 
were divided into two groups. Animals of group I received 0.5% CMC and severed as 
control group. Animals of group II received ethanolic extract trial drug (500 mg/kg. 
once daily) dissolved in distilled water for 14 days. On day 14, two hours after 
treatment, the animals were challenged with 0.5 ml of 2% w/v solution of egg 
albumin into the saphenous vein. Guinea pigs were observed for onset of symptoms 
such as dyspnoea and cyanosis, duration of persistence of symptoms and mortality
 [56]
 
Anti-histamine activity 
Effects of diphenhydramine in experimentally produced asthma in guinea pigs 
Aim  
To demonstrate the antagonistic effects of diphenhydramine against histamine 
induced bronchospasm in the guinea pig. 
Principle  
Guinea pig is very sensitive to histamine. When guinea pig is exposed to 
histamine vapour it exhibits bronchospasm, difficulty in breathing and convulsion. 
These effects of histamine are mediated through the action of histamine on H1 
receptors. Diphenhydramine is a H1 receptors blocker. Therefore, diphenhydramine 
prevents the bronchospasm induced by histamine. 
Equipments and other materials required 
Histometer, stop watch, disposable needle and syringes. 
Animal  : Guinea pigs 
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Drug solutions required 
1. Normal saline  
2. Diphenhydramine 5 mg/ml 
3. Histamine diphosphate 30µg/ml 
Procedure  
 Select 4 guinea pigs having body weight between 250-350 g. Fast the guinea 
pigs for 12 hours before the experiment. Divide the guinea pigs into 2 groups of 2 
animals each. Weigh the guinea pigs in each group and mark them for identification. 
Administer the drug solutions as Group I Normal saline 1 ml/kg, Group I 
Diphenhydramine 5 mg/kg. After one hour place each guinea pig in histamine 
chamber and replace the cover. With the help of compressor, spray a finely atomized 
mist of histamine diphosphate from nebulizer in both comparments. Using a stop 
watch record the time of histamine administration. Observe the signs of respiratory 
distress and the animal falling on its side and record the observations. 
 [57]
 
Isolated Guinea Pig Ileum 
 Overnight fasted guinea pigs of either sex weighing 400-600gram were 
sacrificed using cervical dislocation method. The lower most 10cm of ileum was 
removed from the abdomen and placed in a shallow dish containing warm Triode 
solution. Ileum lumen was cleaned by passing through warm 0.9% saline and then 
segments about one inch in length, were made. The mesenteric attachment and blood 
etc. were carefully cleaned and tissues was mounted in a thermostatically controlled 
Dale’s organ bath containing 20ml Triode’s solution under basal tension of 500mg. 
the composition of solution in was Nacl, 137; Cacl2, 1.8; Kcl, 2.7; glucose, 5.55; 
NaHco3, 11.9; Mgcl2, 1; NaH2Po4, 0.4. The solution was continuously bubbled with 
air. The responses to drug were recorded on a student physiography using isotonic 
transducer, which exerted a basal tension equivalent to 500mg load tissue. The issue 
was allowed to equilibrate for 30 min, during which, the bathing solution was 
changed at every 10 min. Increasing concentration of histamine were added to the 
bath and the control cumulative concentration-response curve was constructed
[58]
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Review of siddha drugs 
List of Siddha drugs used in Bronchial Asthma 
 Swasakudoori Mathirai[59] 
 Vasanthakush Magaram[59a] 
 Gowri Chinthamani[59b] 
 Thalisadi Chooranam[8k] 
 Pavala Parpam[59c] 
 Kashthoori Karuppu[59d] 
 Adathodai Chooranam[60] 
 Swasakasa Matthirai[60a] 
 Kodasoori Kuligai[59e] 
 Melagu Chooranam[61] 
 Thalaga karuppu[59f] 
 Karpooradhi Chooranam[62] 
 Swasakrudhum[62a] 
 Sivanar Amirtham [59g] 
 Kandangkathiri Chooranam[63] 
 Thooduvalai nei[59h] 
 Mahathalisapatthira Chooranam[64] 
 Arakku thailam[59i] 
 Soombu theneer[59j] 
 Adhatodai kudineer[59k] 
 Nochi Thailam[59l] 
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3.5. Lateral research 
1. Cyperus rotundus 
Cyperus have Anti-inflammatory and Anti-arthritic activity. 
[65]
 
2. Zingiber officinale 
 Zingiber officinale have anti prolifertive activity, nuroprotective activity, hepato 
protective activity. 
[66]
 
 
3. Carum copitum 
 Aquaous extract of carum copitum have anxiolytic effect. 
[67] 
4. Plumbago zeylanica 
 The bioactive compound plumbagin and extract of plumbago zeylanic root show a 
wide spectrum of anti bacterial activity. 
[68] 
5. Piper nigrum 
 Crude extract of black pepper and its main alkaloid, pipperin possess combination 
of spasmodic activity. 
[69] 
6. Hyocyamus niger 
 Hyocyamus niger have a spasmolytic, antidiarrheal, bronchodialtory and urinary 
bladder relaxant property. 
[70] 
7. Terminalia chebula 
 Terminalia chebula have anti-oxidant, anti-arthritic, anti-diabetic, 
cardioproductive and hepatoproductive activity. 
[71] 
8.Piper longum 
 The fruit effectively reduce the passive cutaneous anaphylaxis in rats and protect 
guinea pigs against antigen induced bronchospasm. 
[72]  
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4. MATERIALS AND METHODS 
In this dissertation “Kadukai Vadagam” was taken as a trial drug from the Siddha 
literature ‘’Athmaratchamirtha Vaidhiya Saara Sangiragam (part 2)’’ of Kandasamy 
Mudaliyar, published by Dept of Indian Medicine & Homoeopathy 3
rd
 Edition,  2010. 
Ingredients of the drug  
1. Kadukkai (Terminalia chebula)   - 500gm 
2. Kalluppu (Sodium chloride)    - 125gm 
3. Korai kizhangu (Cyperus rotandus)   - 12.6 gm 
4. Kurochani omam (Hyoscyamus niger)  - 12.6 gm 
5. Chukku  (Zingiber  officinale)              - 12.6 gm                          
6. Kodiveli Ver (Plumbago indica)   - 12.6 gm                                                
7. Thippili  (Piper longum)    - 12.6 gm 
8. Chevuiyam (Piper nigrum)    - 12.6 gm 
9. Thippili moolam (Piper longum)    - 12.6 gm 
10. Milagu (Piper nigrum)    - 17.5gm    
11. Induppu (Sodium chloride impura)   - 17.5gm                    
12. Omam (Carum copticum)    - 17.5gm  
Associated drugs 
13. Inji charu (Zingiber  officinale)   - 100ml 
14. Elumichai charu (citrus lemon)                       - 100ml 
15. Butter milk - 100ml 
Collection of the raw materials 
 All the raw materials were bought from Ramasamy chetty country drug store, 
Parry’s corner, Chennai. 
Identification and Authentication of the drug 
 All the raw materials were identified and authenticated by the experts of 
Gunapadam, Government Siddha medical college, Arumbakkam, Chennai-106. The 
specimen sample of all the raw drugs have been preserved in PG Gunapadam department 
individually for future reference. (Reg:GSMC/PG GM/0029-43/2014-2017). 
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4.1. Preparation of the drug 
Purification of the drug 
All the raw material were purified individually as per the Siddha literature. 
1. Kadukkai- Roasted in pan, inner seed was removed. 
2. Kalluppu- It is dissolved in vinegar and clean with a cloth, dried in sun shade. 
3. Korai kizhangu –It was sun dried. 
4. Kurochani omam-Dust and odd materials were removed. 
5. Chukku-It was immersed by using limewater then it was dried in sunlight,  
    finally the above skin was removed. 
6. Kodiveli Ver- Soaked in limewater for 15 minutes and taken. 
7. Thippili- Immersed in lemon juice and dried. 
8. Sevviyam-Outer skin was peeled off and dried in sun.  
9. Thippili moolam- Nodes were removed & dried.  
10. Milagu-It was immersed in sour buttermilk for 75 minutes and dried. 
11. Induppu –Dissolved in vinegar, filtered and dried. 
12. Omum –It is immersed in limewater then it was dried in sunlight. [73] 
Preparation of the trial drug-Kadukkai Vadagam 
 After purification all the processed raw material were taken and altogether to obtain 
fine powder form ginger juice was added to the obtained powder and ground well. This 
process was repeated with lemon juice and butter milk respectively and made into pills.                    
Preservation of the drug 
 Pills were stored in a clean, air tight glass container and labelled as KV 
Administration of the drug 
 Route of Administration: Internal 
 Dose: 1 - 2 Vadagam (2 - 4gm) 
Indication: Bronchial asthma, inflammation, pain and dropsy. 
4.2. Standardization of the drug 
World Health Organization (WHO) has appreciated the importance of medicinal 
plants for public health care. The process of evaluating the quality and purity of herbo 
mineral drugs by means of various parameters like physical, chemical and biological 
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observation is called standardization. Standardization of the this drug comes under the 
following categories 
 Physio-chemical analysis 
 Phyto chemical analysis 
 Bio chemical analysis 
Organoleptic evaluation 
The Organoleptic characters of the sample were evaluated which include 
evaluation of the formulation by its colour, odour, size etc. 
1. Colour examination 
Ten tablets were taken into watch glasses and positioned against white back 
ground in white tube light. Its colour was observed by naked eye and results are noted 
table- 6. 
2. Odour examination 
Ten numbers of tablets were smelled individually. The time interval among two 
smelling was kept two minutes to overturn the effect of previous smelling. Odour of  
Kadukkai Vadagam was noted in results table -6.  
3. Size examination 
The diameter of ten tablets was measured by Vernier caliper. The mean value of 
diameter was noted.  
4.2.1. Physico-chemical investigation 
Physico‐chemical studies like total ash, water insoluble ash, acid Insoluble ash, 
loss on drying at 105°C and pH were done at, Central Research Institute, Chennai. 
Solubility Test 
A pinch of the sample KV was taken in a dry test tube and shaken well with 
distilled water. A little amount of the sample KV is shaken well with con.Hcl and then 
Con. H2SO4. Solubility was observed.  
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Determination of Total Ash 
About 2 g of the ground drug KV was accurately weighed in a silica dish and 
incinerated at a temperature not exceeding 450º until it was free from carbon, cooled and 
weighed. The percentage of ash with reference to the air-dried drug was calculated. 
Determination of Water Soluble Ash 
Total ash was heated up to 600
0
C with 25 ml of distilled water for 10 minutes and 
the residue was ignited in the furnace to get a constant weight. And the weight was 
calculated. 
Determination of Acid Insoluble Ash 
The ash obtained was boiled for 5 minutes with 25 ml of dilute hydrochloric acid 
and insoluble matter was collected in an ash-less filter paper, washed with hot water and 
put up in flames to constant weight. The percentage of acid-insoluble ash with reference 
to the air dried drug was noted.   
Determination of Moisture Content (Loss on Drying) 
This procedure was done to determine the amount of volatile matter in the drug. A 
sample of 10 gram of the drug KV was placed in a tarred evaporating dish after accurately 
weighting without preliminary drying. The dish was dried at a temperature of 105
0
C for 
about 5 hours and again weighed. The drying and weighing procedure was repeated again 
and again until the difference between two successive weights was not more than 0.25%. 
And the weight was calculated. 
pH value 
Potentiometrically pH value was determined by a glass electrode and a pH meter. 
The pH of the KV was written in results column.  
Tablet Disintegration test 
Each KV was placed in each of the six tubes of the basket present in the 
disintegration apparatus. The apparatus was operated by using water as the immersion 
fluid maintained at 35-39 °C. At the end of the 30 min, the basket is lifted from the fluid 
and the state of the tablet is observed. The disintegration time of KV was recorded
 [74] 
 
MATERIALS AND METHODS 
BRONCHODIALATOR ACTIVITY OF KADUKKAI VADAGAM 58 
Weight variation test 
It was carried out to make sure that, each number of tablets contains the proper 
amount of drug. The test was carried out by weighing the 20 tablets individually using 
analytical balance, then the average weight was calculated, and comparing the individual 
tablet weights to the average
 [75]
.  
The percentage of weight variation is calculated by using this formula.  
% of wt. variation =    Individual wt. – Average wt.  x 100 
Average wt. 
   Table 2:- Weight variation limits of Tablets (IP) 
Average weight of tablets 
Maximum percentage of 
weight difference allowed 
80 mg or less ± 10.0 
Between 80 mg and 250 mg ± 7.5 
250 mg and more ± 5.0 
4.2.2. Phytochemical analysis 
The phytochemical screening of KV extract was assessed by standard method. 
Phytochemical screening was carried out on the KV extract using aqueous extract to 
identify the major natural chemical groups such as tannins, saponins, flavonoids, phenols, 
terpenoids, alkaloids, glycosides, cardiac glycosides, coumarins and steroids. General 
reactions in these analyses revealed the presence or absence of these compounds in the 
Kadukkai Vadagam extract tested 
[76]
 
1. Test for Tannins  
For tannin identification, 1 ml of the plant extract, one ml of ferric chloride (5% 
FeCl3) was added. Formation of dark blue or greenish black indicates the presence of 
tannins. 
2. Test for Saponins 
For saponin identification, 2ml Plant extract, 2ml of distilled water was added and 
shaken in graduated cylinder for 15 minutes lengthwise, and formation of 1cm layer of 
foam indicates the presence of saponins. 
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3. Test for Quinones 
For Quinones identification, 1ml Plant extract, 1ml of concentrated sulphuric acid 
(H2SO4) was added. Formation of red colour indicates the presence of Quinones. 
4. Test for Flavonoids 
For flavonoids identification, 2ml of plant extract, 1ml of 2N sodium hydroxide 
(NaOH) was added. Formation of yellow colour indicates the presence of flavonoids.  
5. Test for Alkaloids 
For Alkaloids identification, 2ml Plant extract, 2ml of concentrated Hydrochloric 
acid (Hcl) was added. Then few drops Mayer’s reagent was added. Presence of green 
colour or white precipitate indicates the presence of alkaloids.  
6. Test for Glycosides 
For Glycosides identification, 2ml of the plant extract, 3ml of chloroform and 
10% ammonium solution was added. Formation of pink colour indicates the presence of 
glycosides. 
7. Test for Cardiac glycosides  
For Cardiac glycosides identification, 0.5 ml of the plant extract, 2 ml of glacial 
acetic acid and few drops of 5 % ferric chloride were added. This was under layered with 
1 ml of concentrated sulphuric acid. Formation of brown ring at interface indicates the 
presence of cardiac glycosides. 
8. Test for Terpenoids 
For Terpenoids identification, 0.5 ml of the plant extract, 2 ml of chloroform 
along with concentrated Sulphuric acid. Formation of red brown colour at the interface 
indicates the presence of Terpenoids. 
9. Test for Phenols 
For phenol identification, 1ml of the plant extract, 2ml of distilled water followed 
by few drops of 10 % ferric chloride was added. Formation of blue / green colour 
indicates the presence of phenols 
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10. Test for Steroids 
For steroid identification, 0.5 ml of the plant extract, 2 ml of chloroform and 1 ml 
of Sulphuric acid (H2 SO4) were added. Formation of reddish brown ring at interface 
indicates the presence of steroids. 
11. Test for Coumarins 
For coumarins identification, 1 ml of plant extract, 1 ml of 10 % NaOH was 
added. Formation of yellow colour indicates the presence of coumarins. 
12. Test for Anthocyanin and Beta cyanin 
For Anthocyanin and Beta cyanin identification, to 2ml of the plant extract, one 
ml of 2N sodium hydroxide (NaOH) was added and heated for 5 min at 100 °C. 
Formation of bluish green colour indicates the presence of anthocyanin and formation of 
yellow colour indicates the presence of betacyanin. 
4.2.3. TLC/ HPTLC finger print studies  
HPTLC finger printing was carried out as per the reference 
[77]
.  
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add to 5ml of cooled 
concentrated sulphuric acid. Ice was added and stirred well. The solution was stored in 
refrigerator.   
Chromatographic conditions  
Instrument    : CAMAG (Switzerland). 
Sample Applicator  : Camag Linomat - IV applicator with N2  
   gas flow. 
Photo documentation System : Digi store - 2 documentation system with Win  
  Cat & video scan software. 
Scanner   : Camag HPTLC scanner - 3 (030618), Win Cats  
IV. Development Chamber  : Camag HPTLC 10X10, 10 X 20 twin trough  
   linear 
Development chamber. 
Quantity applied  : 5, 10 µl for extracts and 5 µl for standards 
Stationary phase   : Aluminium plate pre-coated with silica gel  
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  60(E. Merck) 
Plate thickness   : 0.2 mm. 
Mobile Phase   : For Chloroform extract - Toluene: Ethyl  
   acetate (9:1) and ethanol extract –  
   Toluene: Ethyl acetate (1:1).   
Scanning wavelength  : 254 nm 
Laboratory condition  : 26 ± 5
o
C and 53 % relative humidity 
The plate was developed up to a height of 8 cm, air dried, spots were observed 
under the UV light at 254 and 366 nm. Finally the plates were derivatized using vanillin-
sulphuric acid reagent heated at 105° till colour spots appeared.  
4.2.4. Bio-chemical analysis  
Preliminary Basic and Acidic radical studies  
Preparation of extract: 
Preparation of the KV extracts was assessed by following method. One gram of 
dried powder of KV materials were extracted with 20 mL aqueous for 1 min using an 
Ultra Turax mixer (13,000 rpm) and soaked overnight at room temperature. The sample 
was then filtered through Whatman No. 1 paper in a Buchner funnel. The filtered solution 
was evaporated under vacuum in a Rota-vator at 40 °C to a constant weight and then 
dissolved in respective solvents. The dissolving rate of the crude extracts was 
approximately 100 %. The solution was stored at 18 °C until use 
[78]  
   Table.No:3 Test for basic radicals 
PROCEDURE OBSERVATION INFERENCE 
Test for Potassium  
A pinch of sample is treated with 2ml of 
sodium nitrate solution and then treated with 
2ml of cobalt nitrate in 30% of glacial acetic 
acid. 
 
Formation of Yellow 
colour precipitate 
 
Presence of 
Potassium 
Test for Calcium 
Taken2 ml of extract in a clean test tube. 
 
No Yellow precipitate 
Presence of 
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Then acetic acid and potassium chromate 
solution were added 
Calcium 
Test For Magnesium 
2ml of extract was taken in a clean test tube, 
few drops of Magnason reagent was added in 
drops. 
 
Formation of Blue  
colour precipitate 
 
Presence  of 
Magnesium 
Test For Ammonium 
2mlof extract was taken in a test tube and 
added few ml of Nessler's reagent. 
 
Appearance of Brown 
colour 
 
Presence of 
Ammonium 
PROCEDURE OBSERVATION INFERENCE 
Test For Sodium 
2 pinches of KV was mixed with HCl and 
made it into paste.  And introduced into the 
blue flame of Bunsen burner. 
 
Appearance of intense 
Yellow colour 
 
Presence of 
Sodium 
Test for Iron (Ferrous) 
2ml of extract was taken in a clean dried test 
tube and conc. HNO3 and ammonium 
thiocyanate were added. 
 
Appearance of Blood 
red colour 
 
Presence of 
Ferrous iron 
Test For Zinc 
 2 ml of the extract was taken in a test tube 
and Potassium ferro cyanide solution was 
added.  
 
Formation of White 
colour precipitate 
 
Presence  of 
Zinc 
Test For Aluminium 
To the 2m1of the extract was taken in a test 
tube sodium hydroxide drops were added to 
it. 
 
White  precipitate 
obtained 
 
Presence of 
Aluminium 
Test For Lead 
2 ml of extract was taken in a test tube and 
added with 2ml of potassium iodide solution. 
 
Yellow  precipitate 
obtained  
 
Presence of 
Lead 
Test for Copper   
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Results were noted and tabulated in Table No:13 
Table.No:4 Test for acidic radical 
To a small portion of a extract dil Hcl was 
added and then hydrogen sulphide gas is 
passed through the solution. 
Black precipitate Presence of 
Copper 
 
Test For Mercury 
2m1 of the extract was taken in a test tube 
and treated With 2ml of  NaoH solution. 
 
Formation of Yellow 
precipitate 
 
Presence of 
Mercury 
Test for Arsenic      
2m1 of the extract was taken in a test tube 
and treated with 2ml of NaoH solution. 
Brownish red   
precipitate obtained 
Presence of 
Arsenic 
PROCEDURE OBSERVATION INFERENCE 
Test for Sulphate 
 2 ml of the extract was taken in clean, dry 
test tube and 5 % barium chloride solution 
was added to it. 
 
Formation of white 
precipitate 
 
Presence of 
Sulphate 
Test for Chloride 
The extract was taken in a test tube and 
then treated with Silver nitrate solution. 
 
Formation of White 
precipitate 
 
Presence of 
Chloride 
Test for Phosphate 
The extract was taken in a test tube and 
treated with ammonium molybdate and 
conc. HNO3. 
 
Formation of Yellow 
precipitate 
 
Presence of 
Phosphate 
Test for Carbonate           
The substance was taken in a clean dry test 
tube and then treated with Conc. HCl. 
 
Formation of 
Effervescence 
Presence of 
Carbonate 
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4.2.5. Availability of microbial load 
Enumeration of bacteria by plate count – agar plating technique 
The plate count technique was one of the most routinely used procedures because 
of the enumeration of viable cells by this method. 
Principle 
This method is based on the principle that when material containing bacteria are 
cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The number of colonies therefore is the same as the number of organisms 
contained in the sample. 
Dilution 
A small measured volume is mixed with a large volume of sterile water orsaline 
called the diluent or dilution blank. Dilution is usually made in multiples of ten. 
A single dilution was calculated as follows  
 
Requirements 
 Sample or Bacterial suspension 
Test for fluoride & oxalate 
2ml of extract was taken in a test tube and 
added with 2ml of dil.acetic acid, 2ml 
calcium chloride solution and then heated. 
 
Formation of cloudy 
appearance 
 
Presence of 
Fluoride & 
Oxalate 
Test For Nitrate 
1gm of the Kadukkai Vadagamwas heated 
with copper turnings and concentrated 
H2SO4 and observed the test tube 
vertically down. 
 
Characteristic changes 
 
Presence of 
Nitrate 
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 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter. 
Procedure 
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
2. Prepare the initial dilution by adding 1 ml of the sample into a 9 ml dilution blank 
labeled 10
-1
 thus diluting the original sample 10 times. 
3. Mix the contents by rolling the tube back and forth between hands to obtain 
uniform distribution of organisms. 
4. From the first dilution transfer 1 ml of the suspension while in motion, to the 
dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the original 
specimen to 100 times. 
5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank with a 
fresh sterile pipette, thus diluting the original sample to 100 times. 
6. Repeat this procedure till the original sample has been diluted 10,000,000 times 
using every time a fresh sterile pipette. 
7. From the appropriate dilutions transfer 1ml of suspension while in motion, with 
there spective pipettes, to sterile petri dishes. Three petri dishes are to use for each 
dilution. 
8. Add approximately 15 ml of the nutrient medium, melted and cooled to 450c, to 
each petri dish containing the diluted sample. Mix the contents of each dish by 
rotating gently to distribute the cells throughout the medium. 
9. Allow the plates to solidity. 
10. Incubate these plates in an inverted position for 24-48 hours at 370c. 
Observation 
Observe all the plates for the appearance of bacterial colonies. Count the number 
of colonies in the plates. 
Calculate the number of bacteria per ml of the original suspension as follows: 
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Results were noted and tabulated in Table No: 15 
4.2.6. Following instrumental analysis is carried out to study quvantitative analysis 
of Kadukkai Vadagam 
FT-IR (Fourier Transform Infra-Red) 
Model   : Spectrum one: FT-IR Spectrometer 
Scan Range   : MIR 450-4000 cm-1 
Resolution   : 1.0 cm-1  
Sample required      : 50 mg, solid or liquid. 
             It is the preferred method of infrared spectroscopy. FT-IR is an important and 
more advanced technique. It is used to identify the functional group, to determine the 
quality and consistency of the sample material and can determine the amount of 
compounds present in the sample. It is an excellent tool for quantitative analysis. 
In FT-IR infrared is passed from a source through a sample. This infrared is 
absorbed by the sample according to the chemical properties and some are transmitted. 
The spectrum that appears denotes the molecular absorption and transmission. It forms 
the molecular fingerprint of the sample. Like the finger print there is no two unique 
molecular structures producing the same infrared spectrum. It is recorded as the 
wavelength and the peaks seen in the spectrum indicates the amount of material present.  
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FT-IR is the most advanced and the major advantage is its Speed, Sensitivity, 
Mechanical Simplicity, and Internally Calibrated. 
 
                    Fig no: 15 Shows Image of  FTIR Analyser 
 
 
XRD (X-RAY POWDER DIFFRACTION) 
Definition 
X-ray powder diffraction is most widely used for the identification ofunknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is important to studies in geology, environmental science, material science and 
biology. 
Applications 
 Characterization of crystalline materials[79]  
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 Identification of fine-grained minerals such as clays and mixed layer clays that are 
difficult to determine optically 
 Determination of unit cell dimensions. 
With specialized techniques, XRD can be used to 
 Determine crystal structures using Rietveld refinement 
 Determine of modal amounts of minerals (quantitative analysis) 
 Characterize thin films samples by 
 Determining lattice mismatch between film and substrate and toinferring stress 
and strain 
 Determining dislocation density and quality of the film by rockingcurve 
measurements 
 Measuring super lattices in multilayered epitaxial structures 
 Determining the thickness, roughness and density of the film usingglancing 
incidence X-ray reflectivity measurements 
 Make textural measurements, such as the orientation of grains, in apolycrystalline 
sample. 
Strengths and Limitations of X-ray Powder Diffraction 
Strengths 
 Powerful and rapid (< 20 min) technique for identification of an unknownmineral 
 In most cases, it provides an unambiguous mineral determination 
 Minimal sample preparation is required 
 XRD units are widely available 
 Data interpretation is relatively straight forward. 
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Fig no:16 Shows Image XRD Analyser 
Limitations 
 Homogeneous and single phase material is best for identification of unknown 
 Must have access to a standard reference file of inorganic compounds 
 Requires tenths of a gram of material which must be ground into a powder 
 For mixed materials, detection limit is ~ 2% of sample 
 For unit cell determinations, indexing of patterns for non-isometric crystalsystems 
is complicated. 
Sample Collection and Preparation 
Determination of an unknown requires: the material, an instrument for grinding, 
and a sample holder. 
 Obtain a few tenths of a gram (or more) of the material, as pure as possible 
 Grind the sample to a fine powder, typically in a fluid to minimize inducing extra 
strain (surface energy) that can offset peak positions, and to 
randomizeorientation.  
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 Powder less than ~10 μm(or 200-mesh) in size is preferred place into a sample 
holder or onto the sample surface. 
 
ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY)  
                     
                                Fig no: 17 Shows Image of ICP-OES Analyser 
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                                    Fig no: 17 Shows Image of ICP-OES Analyser  
 
Manufacturer: Perkin Elmer Model   
Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: An aqueous sample is converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which is a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) in different (atomic and/or ionic) states and 
produce characteristic optical emissions (lights). These releases are separated based on 
their respective wavelengths and their strengths are measured (spectrometry). The 
intensities are proportional to the concentrations of analyses in the aqueous sample. The 
quantification is an external multipoint linear standardization by comparing the emission 
intensity of an unknown sample with that of a standard sample. Multi-element calibration 
standard solutions are prepared from single- and multi element primary standard 
solutions. With respect to other kinds of analysis where chemical speciation is relevant 
(such as the concentration of ferrous iron or Ferric Iron), only total essential 
concentration is analysed by ICP-OES 
[80]
 
Application  
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The analysis of major and minor elements in solution samples.  
Objectives 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements Probes the 
outer electronic structure of atoms. 
Mechanism  
In plasma emission spectroscopy (OES), a sample solution is presented into the 
core of Inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light is collected by the spectrometer 
and passes through a diffraction grating that serves to resolve the light into a spectrum of 
its essential wavelengths. Within the spectrometer, this deflected light is then collected by 
wavelength and amplified to yield an strength of  measurement that can be converted to 
an elemental concentration by comparison with standardization values. The Inductively 
coupled plasma optical emission spectrometric (ICP-OES) analysis was done in SAIF, 
IIT MADRAS, Chennai-36 using Perkin Elmer Optima 5300 DV. Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" sampling 
methods whereby samples are introduced in liquid form for analysis. 100 mg RSP was 
occupied in a clean, dry test tube. To this, 3 ml Nitric acid was added and mixed well and 
allowed for few minutes until the reactions were completed. And then, 25 ml of Refined 
water, was added to prepare digested solution.  
The digested sample solution was shifted into plastic containers and labelled 
properly. It was completed in Bio-chemistry lab, Govt. Siddha Medical College, 
Chennai-106. 
SEM (Scanning Electron Microscope) 
 In scanning electron microscope high-energy electron beam is focused through a 
probe towards the sample material. Variety of signals was produced on interaction with 
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the surface of the sample. This results in the emission of electrons or photons and it is 
collected by an appropriate detector.  
The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample.  
  
                                  Fig: 18 Shows Image SEM Analyser 
4.3. Acute oral toxicity study of Kadukkai Vadagam 
(OECD guideline – 423) [81]  
Introduction 
 The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on average 
2-4 steps may be necessary to allow judgement on the acute toxicity of the test 
substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
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 The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification 
purposes and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test.  
 The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with 
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
Principle of the Test 
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e. 
 
− no further testing is needed 
− dosing of three additional animals, with the same dose  
− dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance to 
one of a series of toxicity classes. 
Methodology 
Selection of Animal Species  
 The preferred rodent species is the wistar albino rat, although other rodent species 
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may be used. Healthy young adult animals are commonly used laboratory strains should 
be employed. Females should be nulliparous and non-pregnant. Each animal, at the 
commencement of its dosing, should be between 6 to 8 weeks old and the weight (150-
200gm) should fall in an interval within±20 % of the mean weight of any previously 
dosed animals.  
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be artificial, 
the sequence being 12 hours light, 12 hours dark. For feeding, conventional laboratory 
diets may be used with an unlimited supply of drinking water. Animals may be group-
caged by dose, but the number of animals per cage must not interfere with clear 
observations of each animal. 
Preparation of animals  
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
Test Animals and Test Conditions  
 Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
Kings institute, Chennai. All the animals were kept under standard environmental 
condition (22±3°C).  The animals had free access to water and standard pellet diet (Sai 
meera foods, Bangalore). 
Preparation of animals  
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
Preparation for acute toxicity studies 
 Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the, Kadukkai Vadagam 
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The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
IAEC approved  Number: IAEC/XLVIII/07/CLBMCP/2016 
Test Substance  : Kadukkai Vadagam  
Animal Source  : Kings Institute, Chennai.   
Animals   : Wister Albino Rats (Female-3+3) 
Age    : >6 weeks 
Body Weight on Day 0 :180-280 gm. 
Acclimatization  : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization  
period. 
Identification of animals : By cage number, animal number and  
 individual marking by using Picric acid. 
Number of animals  : 3 Female/group,  
Route of administration : Oral  
Diet  : Pellet feed supplied by Sai meera foods Pvt  
        Ltd, Bangalore. 
Water    : Aqua guard portable water in polypropylene  
 bottles. 
Housing & Environment : The animals were housed in Polypropylene  
 cages provided with bedding of husk. 
Housing temperature  : Between 22ºC + 3ºC.  
Relative humidity  : Between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study  : 14 Days 
Administration of Doses  
 Kadukkai Vadagam was suspended in water and administered to the groups of 
wistar albino rats in a single oral dose by gavage using a feeding needle. The control 
group received an equal volume of the vehicle. Animals were fasted 12 hours prior to 
dosing. Following the period of fasting, the animals were weighed and then the test 
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substance was administered. Three Female animals are used for each group. The dose 
level of 3, 30,300 and 2000 mg/kg body weight was administered stepwise. After the 
substance has been administered, food was withheld for a further 3-4 hours. The principle 
of laboratory animal care was followed. Observations were made and recorded 
systematically and continuously as per the guideline after substance administration. The 
visual observations included skin changes, mobility, aggressively, sensitivity to sound 
and pain, as well as respiratory movements.Finally, the number of survivors was noted 
after 24 hrs and these animals were then monitored for a further 14 days and observations 
made daily. The toxicological effect was assessed on the basis of mortality. 
Observations 
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the 
first 4 hours, and daily thereafter, for a total of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found 
dead. It should be determined by the toxic reactions, time of onset and length of recovery 
period, and may thus be extended when considered necessary. The times at which signs 
of toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal. 
Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria 
summarized in the Humane Endpoints Guidance Document taken into consideration. 
Animals found in a moribund condition and animals showing severe pain or enduring 
signs of severe distress was humanly killed. When animals are killed for human reasons 
or found dead, the time of death was recorded. 
 
Behaviour 
 The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
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convulsion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of traction, 
piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  head 
movements, sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and coma. 
Body Weight  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
Food and water Consumption 
  Food and water consumed per animal was calculated for control and the treated 
dose groups.  
Mortality 
Animals were observed for mortality throughout the entire period.  
REPEATED DOSE 28-DAY ORAL TOXICITY STUDY OF KADUKKAI 
VADAGAM ON RATS-(OECD 407 guidelines) 
[82] 
 
Test Substance   : KADUKKAI VADAGAM 
Animal Source   : TANUVAS,Madhavaram, Chennai.   
Animals   : Wister Albino Rats (Male -24, and Female-24) 
Age    : >6 weeks 
Body Weight    : 160-180 gm. 
Acclimatization  : Seven days prior to dose. 
Veterinary examination : Prior and at the end of the acclimatization  
  period. 
Identification of animals  : Bycage number, animal number   and     
    individual marking by using    Picric acid 
Diet    : Pellet feed supplied by Sai meera foods Pvt  
  Ltd, Bangalore. 
Water    : Aqua guard portable water in polypropylene  
  bottles. 
Housing & Environment : The animals were housed in Polypropylene  
  cages provided with bedding of husk. 
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Housing temperature  : Between 22ºC + 3ºC.  
Relative humidity  : Between 30% and 70%, 
Air changes    : 10 to 15 per hour  
Dark and light cycle   : 12:12 hours. 
Duration of the study  : 28 Days. 
Table 5  
 
Methodology 
Randomization, Numbering and Grouping of Animals: 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. 
Each group consist of 12 animals (Male -6, and Female-6). First group treated as a 
control and other three group were treated with test drug (low, mid, high) for 28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior to 
the initiation of treatment. Each animal was marked with picric acid. The females were 
nulliparous and non-pregnant. 
Justification for Dose Selection 
         As per OECD guideline three dose levels were selected for the study. They are low 
dose(30 mg/kg), mid dose dose (150 mg/kg), high dose (300 mg/kg). X is calculated by 
multiplying the therapeutic dose of human (2000mg/kg) and the body surface area of the 
rat (0.018). i.e X dose is 30 mg/kg/animal ,5Xmid dose is 150 mg/kg, 10X high dose is 
300 mg/kg. 
 
 
Groups No of Rats 
Group I  Vehicle control (Normal Saline ) 12 (6 male, 6 female) 
Group II Kadukkai Vadagam 30 mg / kg 12 (6 male, 6 female) 
Group III Kadukkai Vadagam 150 mg / kg 12 (6 male, 6 female) 
Group IV Kadukkai Vadagam 300 mg / kg 12 (6 male, 6 female) 
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Preparation and Administration of Dose 
 Kadukkai Vadagamsuspended in with water, It was administered to animals at the 
dose levels of 30, 150 and 300 mg/kg. The test substance suspensions were freshly 
prepared every two days once for 28 days. The control animals were administered vehicle 
only. The drug was administered orally by using oral gavage oncedaily for 28 
consecutive days. 
Observations 
Experimental animals were kept under observation throughout the course of study 
for the following 
Body Weight 
  Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study. 
Food and water Consumption 
 Food and water consumed per animal was calculated for control and the treated 
dose groups.  
Clinical signs  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality 
All animals were observed twice daily for mortality during entire course of  study. 
Necropsy 
All the animals were sacrificed by excessive anaesthesia on day 29. Necropsy of 
all animals was carried out. 
Laboratory Investigations 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
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Haematological Investigations 
Haematological parameters were determined using Haematologyanalyzer.  
Biochemical Investigations  
Biochemical parameters were determined using auto-analyzer. 
Histopathology 
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group than 
the low, then the mid dose group will also be examined. Organs will be collected from 
all animals and preserved in 10% buffered neutral formalin for 24 h and washed in 
running water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an 
auto technicon and then cleared in benzene to remove absolute alcohol. Embedding was 
done by passing the cleared samples through three cups containing molten paraffin at 
50°C and then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained withHaematoxylin-eosin red .
[83] 
Statistical analysis 
Findings such as body weight changes, water and food consumption,hematology 
and blood chemistry were subjected to One-way ANOVA followed by dunnett test using 
a computer software programme – Graph pad  version 5.0 .All data were summarized in 
tabular form, (Table) 
4.4. Pharmacological activity 
 4.4.1. In Vivo Bronchodilator activity of Kadukkai Vadagam Guinea pig 
 Histamine induced bronchoconstriction in guinea pig 
Overnight  fasted  guinea  pigs  were  divided  into  six  groups  each  containing  6 
animals.   
 Group 1 was treated as control,   
 Group 2 received standard drug chlorpheniramine maleate (2 mg / kg).   
 Groups 3 Kadukkai  Vadagam 200 mg / kg.  
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 Group 4 Kadukkai  Vadagam 400mg / kg 
All the doses were given orally once a day for 5 days. Prior to drug treatment each 
animal was placed in the histamine chamber and exposed to 0.2 % histamine aerosol. The 
pre convulsive time (PCT) was determined from the time of exposure to onset of 
convulsions. As soon as the PCT were noted, the animal were removed from the chamber 
and placed in fresh air. Group 2 received Chlorpheniramine maleate. These  animals  
were  again  subjected  to  histamine  aerosol  after  1hr.of  drug  administration  and  
PCT  was determined.  The protection offered by treatment was calculated by using the 
formula
1, 2
.  
Percentage Protection = (1 - T1/T2) X 100    Where, 
T1 = the mean of PCT before administration of test drugs. 
T2 = the mean of PCT after administration of test drugs. 
4.4.2. In vitro antihistaminic activity of Kadukkai Vadagam   isolated guinea pig 
ileum 
Experimental Procedure: 
Guinea pig was sacrificed and a segment from ileum (2 cm) was dissected from 
the terminal ileum and mounted in an organ bath containing Tyrode solution (10 ml) 
between two stainless steel hooks under 0.5 to 1 g initial tension. The lower hook was 
fixed at the bottom of the organ bath and upper one was connected to an isotonic 
transducer. The Tyrode solution composition (pH 7.4) was NaCl-8.0, KCl-0.2, CaCl2-0.2, 
MgCl2-0.1, NaHCO3 -1.0, NaH2PO4-0.05, and Glucose-10.0gms/liter.  
 It was continuously aerated and maintained at 37 ± 0.5ºC. The equilibrium period 
was 60 min and the bath solution was refreshed every 15 min. After equilibrium period, a 
dose response curve for histamine in variant molar concentrations, by maintaining 45 min 
time cycle was taken separately. Results are provided in the table  
Statistical Analysis 
 Ileum contractions induced by agonist were assumed as 100% and reductions 
induced by test drug calculated. Percentage of ileum contraction was expressed as mean ± 
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SEM. Results were analyzed using one-way analysis of variance (ANOVA). Probability 
value less than 0.05 were considered as significant. Results are discussed in table. 
 
 4.4.3. Anti-oxidant activity oF Kadukkai Vadagam 
DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl) in  In-Vitro 
     The radical scavenging activity of different extracts was determined by using 
DPPH assay according to
[84]
.The decrease in the absorption of the DPPH solution after 
the addition of an antioxidant was measured at 517 nm. 
Ascorbic acid (10mg/ml DMSO) was used as reference. 
Principle  
1,1-diphenyl-2-picryl hydrazyl is a stable free radical with red colour which turns 
yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-A) 
can be written as,  
DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability. 
Reagent Preparation 
0.1 mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
Procedure 
Different volumes (1.25-20µg/µl) of KV extracts were made upto 40µl with 
DMSO and 2.96ml DPPH (0.1mM) solution was added. There action mixture was 
incubated in dark condition at room temperature for 20min.After20min,the absorbance of 
the mixture was read at 517 nm. 3ml of DPPH was taken as control. The % radical 
scavenging activity of the KV extracts was calculated using the following formula, 
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Qualitative analysis of antioxidant activity of KV extract 
 The antioxidant activity of KV extract was determined by following the method 
[85]
. 
Quantitative analysis of free radical scavenging activity of KV extract 
The antioxidant activities were determined using DPPH (Sigma-Aldrich) as a free 
radical. 100µl of KV extract were mixed with 2.7ml of methanol and then 200µl of 0.1 % 
methanolic DPPH was added. The suspension was incubated for 30 minutes in dark 
condition. Initially, absorption of blank sample containing the same amount of methanol 
and DPPH solution was prepared and measured as a control (Lee et al., 2005). 
Subsequently, at every 5 min interval, the absorption maxima of the solutions were 
measured using a UV double beam spectra scan (Chemito, India) at 517nm. The 
antioxidant activity of the sample was compared with known synthetic standard of 0.16% 
Butylated Hydroxy Toluene (BHT).  The experiment was carried out in triplicates. Free 
radical scavenging activity was calculated by the following formula: 
% DPPH radical-scavenging = [(Absorbance of control - Absorbance of test Sample) / 
(Absorbance of control)] x 100. 
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5. RESULTS AND DISCUSSION 
Standardization of the test drug 
 Standardisation of the drug is more essential to derive the efficacy, potency of 
the drug by analysing it by various studies. Following are the results of physio 
chemical and phytochemical analysis. Physical characterisation and estimation of 
basic and acidic radicals have been done and tabulated.  
Toxicological results of the drug and pharmacological activity of the drug are 
derived. Its result has been tabulated and interpretation is made below. Thus, it is to 
give a complete justification, to bring the effectiveness of the trial drug Kadukkai 
Vadagam. 
Results  
              Table: 6  Organoleptic characterization of Kadukkai Vadagam 
S.No               Parameter                       Results 
1.  Colour  Dark Brown 
2.  Odour Citrus smell 
3.  Taste Sour in taste 
4.  Sense of touch Hard 
5.  Size 1 cm 
6.  Solubility  
 i Distilled water Soluble 
 ii Benzene Soluble 
 iii Chloroform Soluble 
 iv Carbon tetra chloride Soluble 
 v Xylene Soluble 
 vi Petroleum ether Soluble 
 vii Propylene glycol Not Soluble 
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Table: 7  Physicochemical Analysis  
S.No Parameter Result 
1. PH 3.93 
2. Total Ash 15.12% 
3. Acid Insoluble ash 0.68% 
4. Water soluble ash 3.13% 
5. Loss on drying at 105⁰C 14.22% 
6. Water soluble Extractive 44.00% 
7. Alcohol soluble Extractive 45.81% 
8. Disintegration time 24 min 
Discussion 
 pH value 
 The pH of KV is 3.93 It is weak acidic in nature. 
 This pH level plays a role in enzyme activity by maintaining the chemical  
environment thus regulating the homeostasis. 
 It is also an important factor for drug absorption.  Being weak acidic, the drug 
is more readily absorbed in an acid medium like stomach which enhance the 
bio availability of the drug. 
Total ash 
 Total ash value will determine the amount of minerals and earthy materials 
present in the drug. 
 The total ash value of KV is 15.12% which determines the presence of 
inorganic content. 
Acid insoluble ash 
 The acid insoluble ash value of the drug denotes the amount of siliceous 
matter (dust, sand etc.,) present in that drug. 
 The quality of the drug is better if the acid insoluble ash value is low. 
 Here, acid insoluble ash value of KV is 0.68%. Hence, it represents the 
superior quality of the KV.   
Water soluble ash 
 Water soluble ash is a part of total ash value, which denotes the colloidal or 
crystalline nature of the drug. 
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 Here, the water soluble ash value of is 3.13%, which represents easy 
facilitation of diffusion and osmosis mechanism. 
Loss on Drying (LOD) 
 It indicates the amount of volatile substance and moisture present in the drug. 
 This also indicates the stability and shelf life of the drug. 
 The loss on drying percentage of KV is 14.22 
Being a Vadagam, without incineration process, the moisture content is slightly high. 
Weight variation test    
Table : 8  Uniformity weight variation test result of  KV 
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Discussion 
 Average weight of the KV was noted as 1.98g. Out of 20 tablets tested, 17 
tablet of them lies within ± 5% weight variation and 3 tablet above the limit. 
 According to the limits of weight test cited in the Indian pharmacopoeia, KV 
passed the Uniformity weight test.  
 The uniformity test resembles uniformly distribution of this tablet helps good 
absorption and distribution.  
Table: 9 Results of Phytochemical screening test  
Phytochemicals 
Tested 
KV Aqueous extract 
Alkaloids Absent 
Glycosides Present 
Saponin Present 
Carbohydrate Present 
Phytosterol Present 
Phenol Present 
Triterpene Present 
Flavonoid Absent 
Quinone Absent 
Protein Present 
 
Discussion 
Phytochemicals are natural bioactive compounds, found in plants and fibres, 
which act as a defence system against diseases and more accurately to protect against 
diseases. The phytochemical analysis reveals the presence of Glycosides, Saponin, 
Carbohydrate, Phytosterol, Phenol, Triterpenes and Protein. 
Glycosides
 
 Many plants store chemicals in the form of inactive glycosides, such plant 
glycosides are used as medications. 
 Glycosides inhibit eosinophil accumulation in tissue and allergic 
inflammation. 
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 They can be effectively used for preventing or treating allergic diseases 
associated with inflammation and eosinophil accumulation such as COPD, 
Bronchial asthma and Allergic rhinitis
 [85]
 
Carbohydrates 
 Carbohydrates provide energy for physical activity and functions of the body. 
 Repair of epithelial tissue injury in asthma was made by carbohydrates [86].  
Phytosterol
 
 Plants steroids have potential anti-inflammatory effect. They are important to 
cure the chronic inflammatory diseases like bronchial asthma
 [87]
.  
 Phytosterol exerts anti-oxidant effect [88].  
Saponins 
 It has anti-spasmodic, anti-inflammatory, expectorant and anti-oxidant 
property. 
 Saponins quicker the expulsion of mucus from the lungs [89].   
Phenols 
 Phenol groups are the essential part of many anti-oxidant compounds. 
 They possess rich Anti-Oxidant property and protect body from oxidative 
stress. 
 It has anti-inflammatory property [90].  
Triterpene
 
 They possess Anti-oxidant, Anti-inflammatory and mucolytic activity. 
 Suppress the inflammatory response 
 They are often expectorant 
Proteins 
 
 Protein is an important component of every cell in the body. 
 Body uses protein to build and repair tissues. 
 Amino acids delay the progressive nature of the diseases and aging process. 
A synergistic effect of all these Glycosides, Saponin, Carbohydrate, Phytosterol, 
Phenol, Triterpenes and Protein increases the potency of the drug against Bronchial 
asthma. 
[92]
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TLC/HPTLC analysis of chloroform extract 
HPTLC analysis 
 Chloroform extract was applied in TLC aluminium sheet silica gel 60 (E. 
MERCK) and plate was developed using the solvent system Toluene: Ethyl acetate 
(9:1). After development, the plate is allowed to dry in air and examined under UV - 
254nm, 366 nm and Visible light (Vanillin - Sulphuric acid). 
TLC Photo documentation : Kadukkai Vadagam 
Stationary Phase - Silica Gel 60 F254 
Mobile Phase – Toluene:ethyl acetate:formic acid (1:1:0.2)  
Table: 10 Rf Values for the chloroform extract of KV 
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HPTLC Chromatogram of scanning  
 
 
                      Fig no:19 shows HPTLC Chromatogram of scanning at 254 nm - 5µl   
 
 
Table no: 11 Chromatogram of scanning at 254 nm - 5µl 
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HPTLC Chromatogram of scanning  
 
 
Fig no: 20 shows Chromatogram of scanning at 254 nm - 7µl 
                
 
Table no: 12 Chromatogram of scanning at 254 nm - 7µl 
 
 
 
 
RESULTS AND DISCUSSION  
BRONCHODIALATOR ACTIVITY OF KADUKKAI VADAGAM  94 
 
HPTLC Chromatogram of scanning  
 
Fig no: 21 shows Chromatogram of scanning at 254 nm-10µl 
 
 
Table no: 13 Chromatogram of scanning at 254 nm - 10 µl 
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3D Chromatogram of 254 nm 
 
                           Fig no: 22 shows 3D Chromatogram of 254 nm 
Discussion 
A qualitative fingerprinting of Kadukkai Vadagam has been performed by 
HPTLC method, which provides qualitative insights into the bioactive Constituents 
present in the drug. HPTLC shows separation of components present in the 
Chloroform extract of Kadukkai Vadagam. The method may be applied to identify the 
Kadukkai Vadagam from other manufacturing process.  
The present study revealed that Kadukkai Vadagam showed best results in 
Toluene: Ethyl Acetate: 9:1 solvent system. After scanning and visualizing the plates 
in absorbance mode at both 254 nm, 366 nm and visible light range, best results were 
shown at 254 nm.  
TLC plate showed different colour phyto constituents of chloroform extract of 
Kadukkai Vadagam. The bands revealed presence of six greenish, four blue, one dark 
blue, three bright blue, eight grey, one brown bands showing the presence of 
glycosides, carbohydrate, phytosterol, alkaloids, phenol, triterpene and saponins. 
The results from HPTLC finger print scanned at wave length 254 nm for 
chloroform extract of Kadukkai Vadagam. There are ten polyvalent phyto constituents 
and corresponding ascending order of Rf values start from 0.05 to 0.89 in which 
highest concentrations of the phyto constituents was found to be 44.97 % and 10.88 % 
with its corresponding Rf value were found to be 0.22 and 0.75 respectively. 
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Bio chemical analysis 
Preliminary Basic and Acidic Radical Studies  
Table: 14 Results of basic radicals studies 
S.NO 
Parameter Result 
1 Test for Potassium + ve 
2 Test For Sodium + ve 
Interpretation 
 The basic radical test shows the presence of  Potassium, Sodium and absence 
of heavy metals such as lead, arsenic and mercury. 
 A sodium and potassium cell-signalling channel plays almost important role in 
regulatory part of the respiratory system, breathing rhythm, and the body’s 
response to insufficient oxygen levels. So, this drug stimulates normal 
respiratory mechanism
[93]
. 
Results of acid radical studies 
 Table: 15 shows Results of acid radical studies 
S.No Parameter Result 
1. Test for Chloride + ve 
2. Test for Phosphate + ve 
Interpretation 
 The acidic radicals test shows the presence of Chloride, Phosphate.  
Chloride 
 Chloride is needed to keep the proper balancing of body fluids [94] 
 It maintains proper blood volume and pressure [95].    
 It plays critical roles in inflammatory airway diseases such as Bronchial 
asthma and Allergic rhinitis 
[96]
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Phosphate 
 Phosphate is a charged particle that contains the mineral phosphorus [97] 
 The mineral Phosphorus is primarily used for growth and repair of body cells 
and tissues
 [98]
 
 It reduces the histamine release by activated mast cells [99] 
Microbial load 
Availability of bacterial and fungal load in Kadukkai Vadagam  
Bacterial and fungal dilutions  
Table no: 16 Availability of bacterial and fungal load in KV 
 MICROBES DILUTION RESULT 
Bacteria 10
-4 
7 
Bacteria 10
-6 
4 
Fungi 10
-2 
6 
Fungi 10
-3 
4 
Discussion 
 The Herbo-mineral drug are prepared from plant material they are prone to 
contamination. The contamination of herbal drugs by microorganism not only cause 
bio deterioration but also reduces the efficacy of drugs. 
 The toxin produce by microbes makes herbal drugs unfit for human 
consumption because the contaminated drug may develop unwanted disease instead of 
disease being cured. 
 Here the contaminations of KV have been examined by bacterial and fungal 
load. 
 Total bacterial load in 10-4 dilution is 7 and in 10-6 dilution is 4. 
 Total fungal load in 10-2 dilution is 6 and in 10-3 dilution is 4.  
 Hence the contamination of KV is within the WHO norms. Hence, the drug is 
collected, prepared, stored and packed and decontaminated prior to formulation. 
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Instrumental analysis 
FTIR  
Fourier Transform Infra-Red Spectroscopy (FTIR) analysis results in 
absorption spectra provide information about the functional group and molecular 
structure of a material.   
 
Fig no: 23 shows FTIR Analysis 
Table: 17 shows FT-IR Analysis of Kadukkai Vadagam 
Frequency 
cm
-1 
Stretch Functional group 
3423 OH-stretch, H-bonded Alcohols, Phenols 
1626 N-H bond 1
◦ 
Amines 
1085 C-O stretch Alcohols, Carboxylic acid, Esters, 
Ethers  
779 N-H,C-H=C-H 1
◦
, 2
◦
 Amines, Aromatics, Alkenes. 
797 N-H,C-H=C-H 1
◦
,2
◦
 Amines, Aromatics, Alkenes 
694 C-H 
“
oop
” 
Aromatics. 
659 C-H bond Alkenes 
553 C-Br stretch Alkyl halides 
501 C-Br stretch Alkyl halides 
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Discussion 
 FTIR instrumental analysis was done. The test drug was identified to have 9 
peaks. They are the functional groups present in the trial drug Kadukkai Vadagam. 
 The above table shows the presence of Alcohol, Phenols, Esters, Amines, 
Acid, Aromatics, Alkyl halides, Alkene, Ether and Alkanes which are represents the 
peak value. 
 OH group has higher potential towards inhibitory activity against airway 
inflammation. 
[100]
 
 Amines and Carboxylic acids enhances the drug effect against the disease. [101] 
SEM (Scanning Electron Microscope with Energy Dispersive X-Ray Analysis) 
In addition, the particle size and chemical elements were assessed by Scanning 
Electron Microscope. SEM is one of the most widely used instrument in research 
areas. 
 
 
Fig no:24 SEM images shows the partical size of KV is 2 – 5µ  
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Intrepretation 
 The SEM reveals the micro size (2 – 5 µ ) particle of the sample. 
 Size and surface of micro particles can be easily manipulated to achieve both 
passive and active drug targeting. 
ICP-OES (Inductively Coupled Plasma Optical Emission Spectroscopy) 
The drug (Kadukkai Vadagam) sample was analysed by the Inductively 
Coupled Plasma Optical Emission Spectroscopy (ICP-OES) to detect the trace 
elements and other elements quantitatively. The result of ICP-OES is given on the 
Table no:17.  
Table no: 18 ICP-OES of Kadukkai Vadagam 
S. 
no Elements 
Wavelength 
(nm) 
Kadukkai 
Vadagam 
100mg 
1. Al 396.152 BDL 
2. As 188.979 BDL 
3. Cd 228.802 BDL 
4. Cu 327.393 BDL 
5. Hg 253.652 BDL 
6. K 766.491 53.820 mg/L 
7. Na 589.592 04.300 mg/L 
8. Ni 231.604 BDL 
9. Pb 220.353 BDL 
10. P 213.617 225.740 mg/L 
11. Al 396.152 BDL 
12. As 188.979 BDL 
13. Cd 228.802 BDL 
14. Cu 327.393 BDL 
BDL : Below Detectable Limit 
% = 10000ppm, 
1ppm = 1/1000000 or 1ppm = 0.0001% 
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The toxic metals and the permissible limits  
Table no:19  The toxic metals and the permissible limits 
Heavy metals WHO & FDA limits 
Arsenic (As)              10 ppm 
Mercury (Hg)              1 ppm 
Lead (Pb)             10 ppm 
Cadmium (Cd)             0.3 ppm 
Interpretation 
The result indicate that the formulation is extremely safe as it contains heavy 
metals below detectable limits.  
ICP-OES reveals high concentration of P in Kadukkai Vadagam. It also 
possess Na and K. Phosphorous is also used in treating asthma with symptoms of 
accumulation of mucus in the bronchi, dyspnoea and the sensation of heat in the chest, 
aetiology being temperature changes in atmosphere. Bichromate form of potassium 
relieves hyper production of mucus. 
[102] 
XRD 
 
Fig.no:25 XRD images of KV 
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Interpretation 
 The structure, the size and shape of the particles are highly dependent on the 
route of synthesis and high lights the efficacy of the drug. The micro particles may 
enhance bio absorbtion of the drug. 
 The major diffraction peaks are identified after  XRD analysis is KV 
concluded that range is 45-60 nm is association with organic molecules probably  
place an important role in making it biocompatible and nontoxic at therapeutic doses. 
Other elements present in KV act has additional supplement and possibly helps in 
increases the efficacy of the formulation. 
 Toxicity studies 
Acute oral toxicity study of Kadukkai Vadagam 
Table: 20 Dose finding experiment and its behavioural signs of acute oral Toxicity Observation  
 
S.No Physical Parameters 
Observation 
Control group Test group 
1 Body weight Normal Normally increased 
2 Assessments of posture Normal Normal 
3 
Signs of Convulsion 
Limb paralysis 
Normal Absence of sign (-) 
4 Body tone Normal Normal 
5 Lacrimation Normal Absence 
6 Salivation Normal Absence 
7 Change in skin color 
No significant color 
change 
No significant color 
change 
8 Piloerection Normal Normal 
9 Defecation Normal Normal 
10 Sensitivity response Normal Normal 
11 Locomotion Normal Normal 
12 Muscle gripness Normal Normal 
13 Rearing Mild Mild 
14 Urination Normal Normal 
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Table : 21  (Observational study Results) 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping  
6. Touch Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions  
10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia  
15. Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration  
20. Mortality. (+ Present, - Absent) 
Table: 22( Body weight Observation)  
 
Table: 23 (Water intake (ml/day) of Wistar albino rats group exposed to K V 
 
N.S- Not Significant,**(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
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Table: 24 Food intake (gm/day) of Wistar albino rats group exposed to K V 
 
Discussion 
The acute toxicity result shows no mortality rate up to 2000mg/body weight 
per kg. It showed changes in alertness, grooming, touch response. The behavioural 
changes are normal. Hence the test drug Kadukkai Vadagam is a safe herbal drug and 
can be used for long time administration.  
Repeated Dose 28- days oral toxicity study of Kadukkai Vadagam 
Table: 25 Body weight of wistar albino rats group exposed to KV 
  
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
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Table: 26 Water intake (ml/day) of Wistar albino rats group exposed to K V 
 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
 
 
Table: 27 Food intake (gm/day) of Wistar albino rats group exposed to KV 
 
 
 
 N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test 
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Table: 28 Haematological parameters of Wistar albino rats group exposed to KV 
 
 
 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
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Table: 29 Biochemical Parameters of Wistar albino rats group exposed to KV 
 
 
 
NS- Not Significant,**(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test)  
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Table: 30 Renal function test of Wistar albino rats group exposed to KV 
 
  
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
Table: 31 Liver Function Test of of Wistar albino rats group exposed to 
Kadukkai Vadagam 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
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Discussion 
The dose selected for the repeated oral toxicity study was 100mg, 200mg/kg 
of Kadukkai Vadagam 
 All the animals were free of intoxicating signs throughout the dosing period of 
28 days. No physical changes were observed throughout the dosing period. No 
mortality was observed during the whole experiment. No abnormal deviations were 
observed. No significant changes were observed in the values of different parameters 
studied when compared with controls and values obtained were within normal 
biological and laboratory limits.  
 The weights of organs and body weight recorded did not show any significant 
differences in the treatment and the control group indicating that Kadukkai Vadagam 
was not toxic to kidney, liver and spleen. 
 There was no significant changes were observed in haemoglobin (Hb), Red 
blood cell (RBC), White blood cell (WBC), Packed cell volume (PCV), Erythrocyte 
sedimentation rate (ESR) in all the treated groups as compared to respective control 
groups. 
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Repeated Oral Toxicity Study Histo pathology 
Control Kadukkai Vadagam(300 mg/kg) 
Lungs  
  
Kidney  
 
 
   Liver  
  
Spleen  
    
Fig no: 26 shows Histopathology slides. 
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Interpretation 
 The above slides show the histopathology studies of repeated oral toxicity 
study. There is no toxicological abnormality seen in the vital organs after 
administration of the test drug Kadukkai Vadagam. Thus the safety of the drug is 
revealed so that it can be administered for long time without any side effects. 
Pharmacological study  
Bronchodilator activity  
Effect of Histamine induced bronchoconstriction in guinea pig: 
Table No: 32 shows Histamine induced bronchoconstriction in guinea pig 
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              Chart: 1 shows Bronchodilator action of Kadukkai Vadagam 
Discussion 
From the above results, we can confirm that Kadukkai Vadagam possesses 
bronchodilator activity nearer to fifty percentage when compared with 
chlopheniramine maleate as a standard drug. 
Anti – histamine activity 
Table: 33 Effect of Kadukkai Vadagam isolated guinea pig ileum preparation.  
 
Values are expressed in mean ± SEM, *p< 0.05; **p< 0.01, ***p<0.001compared 
with histamine alone (45mm as 100%); n=3.  
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Chart: 2  shows Anti histamine activity 
Discussion  
Mediators like histamine, serotonin, and acetylcholine are implicated in 
various ways in the pathogenesis of Asthma. Histamine is the most implicating 
mediator in broncho constriction that accompany asthma although the role of 
serotonin in asthma is uncertain. KV inhibited the histamine induced bronchospasm 
(vascular permeability) in rats, when compare with cetrizine as standard. Here, KV 
possesses the Anti-histamine activity. 
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Anti oxidant activity 
               Table: 34 DPPH Assay of KV 
 
 
*µg/ml: microgram per millilitre. Drug:  Kv(1.25-20µg/µl). Standard: Ascorbic 
acid(10mg/mlDMSO) 
                   
                                Chart: 3 shows Anti-oxidant activity 
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Discussion 
Anti oxidants can compensate the oxidative stress that correlates with asthma, 
can reduce the symptoms of asthma and improve pulmonary functions. 
 Oxidative stress resulting from a increased amount of reactive oxygen speices 
and an imbalance between oxidants and anti oxidants plays an important role in the 
pathogenesis of asthma.
[103]
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6. CONCLUSION 
The trial drug “Kadukkai Vadagam” was taken from the Siddha literature 
“Athmaratchamirtha Vaidhiya Saara Sangiragam (part 2)’’ to evaluate the safety 
and efficacy of the drug in Swasakasam (Bronchial asthma). 
The ingredients of the trial drug was identified and authenticated by the 
experts of Gunapadam. By the classical methods, ingredients of the trial drug 
Kadukkai Vadagam was purified and the drug was prepared. In the purification 
process toxins was eliminated and increases its efficacy. In the grinding process of 
this drug particle size of the drug became into nana particle for its better bio 
availability. 
Phytochemical analysis of the drug shows presences of glycosides, saponins, 
carbohydrates, Phytosterol, Phenol, Triterpenes and Protein.  A synergistic effect of 
all these Glycosides, Saponin, Carbohydrate, Phytosterol, Phenol, Triterpenes and 
Protein increases the potency of the drug against Bronchial asthma. 
Biochemical analysis of basic radicals confirms the presence of Potassium and 
Sodium. A sodium and potassium cell-signalling channel plays almost important role 
in regulatory part of the respiratory system, breathing rhythm, and the body’s 
response to insufficient oxygen levels. So this drug stimulates normal respiratory 
mechanism. 
          Biochemical analysis of acid radicals shows the presence of Chloride, 
Phosphate. Chloride plays critical roles in inflammatory airway diseases such as 
Bronchial asthma. 
Instrumental analysis FT-IR results shows presence of Alcohol, Phenols, 
Esters, Amines, Acid, Aromatics, Alkyl halides, Alkene, Ether and alkanes groups. 
Alcohol group has anti asthmatic effect. It has higher potential towards inhibitory 
activity against airway inflammation.  
SEM picture shows micro particle sizes. It represents the drug is more 
absorbable and easily to reach the cell.  
ICP-OES results show the presence of Phosphorus, Sodium, and Potassium. 
Phosphorus is best suited for cough that occurs with asthma. So it is indicated in the 
treatment of bronchial asthma. 
Kadukkai Vadagam did not produce any oral acute or sub-acute toxicity in 
rats. So the drug is non-toxic and safe. The histopathology studies of acute and sub-
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acute toxicity shows that there is no toxicological abnormality seen in the vital organs 
after administration of the test drug Kadukkai Vadagam. 
Kadukkai Vadagam could be conformed as No-Observed-Adverse Effect 
Level (NOAEL) drug as it acts harmless under normal usage and to be of no 
toxicological concern. 
After evaluate the safety the drug, the Bronchodilator and anti-histaminic 
property of Kadukkai Vadagam is elaborated. So it can be concluded that this drug 
inhibits the tone of tracheal and bronchial muscles and thus has a bronchodilator 
action. It is possible that anti-histamine activity of the Kadukkai Vadagam mainly 
involves inhibiting the histamine induced bronchospasm. The KV extract has more or 
less equal DPPH scavenging activity when compared to the standard. The KV extract 
has a marked antioxidant activity at higher concentrations. 
From the above scientific evaluation, the author concludes that the drug 
Kadukkai Vadagam is proficient with the new hope in the treatment of Bronchial 
asthma which is cost effective and has fair preparation method. 
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7. Summary 
In our Siddha literature symptoms of the Swasa kasam was correlated with 
bronchial asthma. Generally due to the imbalance of the prana vayu, three humours in the 
body gets vitiated, then it leads to broncho constriction. 
Hence the author conducts the detailed scientific validation of Kadukkai Vadagam 
for Bronchodilator activity, Anti-oxidant activity and Anti-histamine activity. 
The study was accepted by Institutional screening committee and then approved 
by the Institutional Animal Ethical Committee (IAEC). 
In this study, various types of analyzing studies for efficacy and toxicity were 
conducted in the SCRI and Baid Metha College.  
In the Organoleptic studies KV has dark brown colour, sour in taste, hard in touch, 
1cm in size and slightly soluble in water. 
In the Physiochemical analysis studies, KV has contains Total ash 15.12%, Water 
soluble ash 3.13%, Acid insoluble ash 0.68%, Water soluble extractive 44.00%, Alcohol 
soluble extractive 45.81%. 
The phytochemical analysis reveals the presence of Glycosides, Saponin, 
Carbohydrate, Phytosterol, Phenol, Triterpenes and Protein which act as a defence system 
against diseases and more accurately to protect against swasa kasam diseases. 
In HPTLC analysis finger print scanned at wave length 254 nm for chloroform 
extract of KV. There are ten polyvalent phyto constituents and corresponding ascending 
order of Rf values start from 0.05 to 0.89 in which highest concentrations of the phyto 
constituents was found to be 44.97 % and 10.88 % with its corresponding Rf value were 
found to be 0.22 and 0.75 respectively. 
In the Bio-Chemical analysis of the KV drug contains Sodium, Potassium which 
stimulates normal respiratory mechanism in bronchial asthma. 
In the examination of KV drug, bacterial and fungal load has within the WHO 
norms. Hence the drug KV is safe. 
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In the FTIR instrumental analysis, the drug  KV contains presence of Alcohol, 
Phenols, Esters, Amines, Acid, Aromatics, Alkyl halides, Alkene, Ether and alkanes 
which are represents the peak value. OH group has higher potential towards inhibitory 
activity against airway inflammation. Amines and Carboxylic acids possess which 
enhances the drug effect against the disease. 
In the SEM Analysis, KV drug contains the micro size particle of the sample. 
ICP-OES results indicate that the formulation is extremely safe as it contains 
heavy metals below detectable limits.  
XRD  pattern of the trail drug KV shows some good crystalinity. The major 
diffraction peaks are identified after XRD analysis 
The acute toxicity result shows no mortality rate up to 2000mg/kg. It showed 
changes in alertness, grooming, touch response. The behavioral changes are normal. 
Hence the test drug KV is a safe herbal drug and can be used for long time administration.  
There is no toxicological abnormality seen in the vital organs after administration 
of the test drug KV. Thus the safety of the drug is revealed so that it can be administered 
for long time without any side effects. 
In the Pharmacological study KV possesses bronchodilator activity, Anti-
histamine activity and Anti oxidants. Hence It can reduce the sympotoms of asthma and 
improve pulmonary funtions. 
An incredible action of this drug value against the disease of Bronchial asthma 
has been revealed from this study of. KV.  This must be implicated in the future clinical 
studies and preclinical chronic toxicity studies. 
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8. FUTURE SCOPE 
 
 The trial drug Kadukkai Vadagam has its own potency in treating Bronchial 
asthma in animal model which has been established in this study. An incredible action of 
this drug value against the disease of Bronchial asthma has been revealed from this study 
of Kadukkai Vadagam. This must be implicated in the future clinical studies and 
preclinical chronic toxicity studies. 
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Fig no: 13 Adding zinger juice, lemon juice and butter milk finally in grinding 
process 
 
 
 
 
 
 
Fig no:14  
 
PREPARAION OF THE KADUKKAI VADAGAM 
Kadukkai  vadagam 



